# Bristol-Myers Squibb

id: ent_bristol-myers-squibb  
wikidata: Q266423  
kind: organization  
timeline: /timelines/bristol-myers-squibb.md  
page: /record/bristol-myers-squibb  
same_as: https://asof.is/record/bristol-myers-squibb (how to cite the id: /identifiers.md)  

Bristol-Myers Squibb is an American pharmaceutical company, headquartered in Princeton. Its CEO is Christopher S. Boerner, Ph.D, since 2023. It reported revenue of $48.19B for the period ended December 31, 2025.

## Key facts

- CEO: Christopher S. Boerner, Ph.D (since 2023) · claim: /claim/clm_FF61856A3386.md
- CFO: David V. Elkins · claim: /claim/clm_7B0B3B31B401.md
- Headquarters: Princeton · claim: /claim/clm_C642296F0710.md
- Revenue: $48.19B (to 2025-12-31) [recorded: 48,194,000,000 United States dollar] · claim: /claim/clm_BB9F55DFC7A5.md
- Ticker: BMY · NYSE · claim: /claim/clm_ED7EF0279BF9.md

## Questions

**Who is the CEO of Bristol-Myers Squibb?** Christopher S. Boerner, Ph.D, since 2023, as the AsOf record states with its sources.

**Where is Bristol-Myers Squibb headquartered?** Princeton.

**What is Bristol-Myers Squibb's revenue?** $48.19B for the period ended December 31, 2025.

## Fact pages

One page per fact: the current value with its sources, then every dated value and what replaced what. Fetch any of them as markdown.

- [Bristol-Myers Squibb CEO](/record/bristol-myers-squibb/ceo.md)
- [Bristol-Myers Squibb chair](/record/bristol-myers-squibb/chair.md)
- [Bristol-Myers Squibb CFO](/record/bristol-myers-squibb/cfo.md)
- [Bristol-Myers Squibb headquarters](/record/bristol-myers-squibb/headquarters.md)
- [Bristol-Myers Squibb revenue](/record/bristol-myers-squibb/revenue.md)
- [Bristol-Myers Squibb net income](/record/bristol-myers-squibb/net_income.md)
- [Bristol-Myers Squibb quarterly revenue](/record/bristol-myers-squibb/quarterly_revenue.md)

## Current state

What the record asserts: claims that held, valid by their sources or primary-sourced at confidence 0.7 or more. Unverified, disputed, retracted and review-marked claims are listed below, labelled, not here.

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | registrant_name | BRISTOL MYERS SQUIBB CO | valid undated to present | conf 0.95 | valid | [clm_B021E66EA136](/claim/clm_B021E66EA136.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | ceo | Christopher S. Boerner, Ph.D | valid 2023-11-01 to present | conf 0.95 | valid | [clm_FF61856A3386](/claim/clm_FF61856A3386.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | chair | Christopher S. Boerner, Ph.D | valid 2024-04-01 to present | conf 0.95 | valid | [clm_62358F2F8937](/claim/clm_62358F2F8937.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | headquarters | Princeton | valid undated to present | conf 0.95 | valid | [clm_C642296F0710](/claim/clm_C642296F0710.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 48,194,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_BB9F55DFC7A5](/claim/clm_BB9F55DFC7A5.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 7,054,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_52D44073C808](/claim/clm_52D44073C808.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 88,772,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_ABE255E98610](/claim/clm_ABE255E98610.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | listed_on | NYSE | valid undated to present | conf 0.95 | valid | [clm_7C0328B0E90C](/claim/clm_7C0328B0E90C.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 9,574,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_D7A2CC833948](/claim/clm_D7A2CC833948.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cfo | David V. Elkins | valid undated to present | conf 0.95 | valid | [clm_7B0B3B31B401](/claim/clm_7B0B3B31B401.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 2,162,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_247D46C4A3C2](/claim/clm_247D46C4A3C2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_operating_income | 1,402,000,000 United States dollar | valid 2012-03-31 to present | conf 0.95 | valid | [clm_B92B3F0BD51E](/claim/clm_B92B3F0BD51E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,365,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_F9CEFB4CA8DE](/claim/clm_F9CEFB4CA8DE.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 13,069,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_41E4C7C8DCE2](/claim/clm_41E4C7C8DCE2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 9,951,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_1D1D9926921B](/claim/clm_1D1D9926921B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,044,085,831 shares | valid 2026-10-21 to present | conf 0.95 | valid | [clm_434253DF3386](/claim/clm_434253DF3386.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 23,404,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_724BB1A9B7DC](/claim/clm_724BB1A9B7DC.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm

## All claims

One claim per line, newest first. Superseded claims stay visible.

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,044,085,831 shares | valid 2026-10-21 to present | conf 0.95 | valid | [clm_434253DF3386](/claim/clm_434253DF3386.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 2,162,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_247D46C4A3C2](/claim/clm_247D46C4A3C2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 13,069,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_41E4C7C8DCE2](/claim/clm_41E4C7C8DCE2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 23,404,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_724BB1A9B7DC](/claim/clm_724BB1A9B7DC.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 88,772,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_ABE255E98610](/claim/clm_ABE255E98610.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 9,574,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_D7A2CC833948](/claim/clm_D7A2CC833948.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,365,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_F9CEFB4CA8DE](/claim/clm_F9CEFB4CA8DE.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,042,714,656 shares | valid 2026-07-22 to 2026-10-21 | conf 0.95 | superseded | superseded_by [clm_434253DF3386](/claim/clm_434253DF3386.md) | [clm_5166F8F7F132](/claim/clm_5166F8F7F132.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 22,319,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_724BB1A9B7DC](/claim/clm_724BB1A9B7DC.md) | [clm_083025B827E0](/claim/clm_083025B827E0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 3,317,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_247D46C4A3C2](/claim/clm_247D46C4A3C2.md) | [clm_2F764423414C](/claim/clm_2F764423414C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,959,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_F9CEFB4CA8DE](/claim/clm_F9CEFB4CA8DE.md) | [clm_750726B16C2E](/claim/clm_750726B16C2E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 8,722,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_D7A2CC833948](/claim/clm_D7A2CC833948.md) | [clm_8980CFF36D8A](/claim/clm_8980CFF36D8A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 12,973,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_41E4C7C8DCE2](/claim/clm_41E4C7C8DCE2.md) | [clm_9331256657C6](/claim/clm_9331256657C6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 87,634,000,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_ABE255E98610](/claim/clm_ABE255E98610.md) | [clm_9E417A35E9A3](/claim/clm_9E417A35E9A3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,042,071,247 shares | valid 2026-04-21 to 2026-07-22 | conf 0.95 | superseded | superseded_by [clm_5166F8F7F132](/claim/clm_5166F8F7F132.md) | [clm_8D842E7F4E9F](/claim/clm_8D842E7F4E9F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,489,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_9331256657C6](/claim/clm_9331256657C6.md) | [clm_3BBDC1786FBC](/claim/clm_3BBDC1786FBC.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 2,677,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_2F764423414C](/claim/clm_2F764423414C.md) | [clm_59B16D5CFE58](/claim/clm_59B16D5CFE58.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,649,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_750726B16C2E](/claim/clm_750726B16C2E.md) | [clm_66E70FD09231](/claim/clm_66E70FD09231.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 20,068,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_083025B827E0](/claim/clm_083025B827E0.md) | [clm_BD37E595C6F2](/claim/clm_BD37E595C6F2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 9,574,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_8980CFF36D8A](/claim/clm_8980CFF36D8A.md) | [clm_C1362BDC5761](/claim/clm_C1362BDC5761.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 86,476,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_9E417A35E9A3](/claim/clm_9E417A35E9A3.md) | [clm_EFC619CCF554](/claim/clm_EFC619CCF554.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,036,473,705 shares | valid 2026-02-04 to 2026-04-21 | conf 0.95 | superseded | superseded_by [clm_8D842E7F4E9F](/claim/clm_8D842E7F4E9F.md) | [clm_7BDDFBA6A82F](/claim/clm_7BDDFBA6A82F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 90,038,000,000 United States dollar | valid 2025-12-31 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_EFC619CCF554](/claim/clm_EFC619CCF554.md) | [clm_16735433DCF9](/claim/clm_16735433DCF9.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 9,951,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_1D1D9926921B](/claim/clm_1D1D9926921B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 7,054,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_52D44073C808](/claim/clm_52D44073C808.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 10,209,000,000 United States dollar | valid 2025-12-31 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_C1362BDC5761](/claim/clm_C1362BDC5761.md) | [clm_71B9DA11CD2A](/claim/clm_71B9DA11CD2A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 48,194,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_BB9F55DFC7A5](/claim/clm_BB9F55DFC7A5.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 18,473,000,000 United States dollar | valid 2025-12-31 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_BD37E595C6F2](/claim/clm_BD37E595C6F2.md) | [clm_D808E9CABB64](/claim/clm_D808E9CABB64.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,035,753,027 shares | valid 2025-10-23 to 2026-02-04 | conf 0.95 | superseded | superseded_by [clm_7BDDFBA6A82F](/claim/clm_7BDDFBA6A82F.md) | [clm_5DF65CC84443](/claim/clm_5DF65CC84443.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 18,552,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_D808E9CABB64](/claim/clm_D808E9CABB64.md) | [clm_3AA608585C53](/claim/clm_3AA608585C53.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 15,726,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_71B9DA11CD2A](/claim/clm_71B9DA11CD2A.md) | [clm_8F913554EE54](/claim/clm_8F913554EE54.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 96,889,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_16735433DCF9](/claim/clm_16735433DCF9.md) | [clm_B080F3CCA436](/claim/clm_B080F3CCA436.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 2,201,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_59B16D5CFE58](/claim/clm_59B16D5CFE58.md) | [clm_B6387AF1FB92](/claim/clm_B6387AF1FB92.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 12,222,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_3BBDC1786FBC](/claim/clm_3BBDC1786FBC.md) | [clm_BB784B853512](/claim/clm_BB784B853512.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,528,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_66E70FD09231](/claim/clm_66E70FD09231.md) | [clm_F60212FAE72C](/claim/clm_F60212FAE72C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,035,435,838 shares | valid 2025-07-24 to 2025-10-23 | conf 0.95 | superseded | superseded_by [clm_5DF65CC84443](/claim/clm_5DF65CC84443.md) | [clm_92B2391A76BC](/claim/clm_92B2391A76BC.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,310,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_B6387AF1FB92](/claim/clm_B6387AF1FB92.md) | [clm_08AC6F344E17](/claim/clm_08AC6F344E17.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 17,435,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_3AA608585C53](/claim/clm_3AA608585C53.md) | [clm_35FC8304F747](/claim/clm_35FC8304F747.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 12,599,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_8F913554EE54](/claim/clm_8F913554EE54.md) | [clm_5B41E0056E4E](/claim/clm_5B41E0056E4E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,580,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_F60212FAE72C](/claim/clm_F60212FAE72C.md) | [clm_8BF1DFD17C30](/claim/clm_8BF1DFD17C30.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 12,269,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_BB784B853512](/claim/clm_BB784B853512.md) | [clm_BC0F7635AE7E](/claim/clm_BC0F7635AE7E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 94,676,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_B080F3CCA436](/claim/clm_B080F3CCA436.md) | [clm_EBBD764A8BF3](/claim/clm_EBBD764A8BF3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,035,080,810 shares | valid 2025-04-17 to 2025-07-24 | conf 0.95 | superseded | superseded_by [clm_92B2391A76BC](/claim/clm_92B2391A76BC.md) | [clm_42F9567D36B6](/claim/clm_42F9567D36B6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,257,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_8BF1DFD17C30](/claim/clm_8BF1DFD17C30.md) | [clm_521ADD71267C](/claim/clm_521ADD71267C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 10,875,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_5B41E0056E4E](/claim/clm_5B41E0056E4E.md) | [clm_544A85081CFD](/claim/clm_544A85081CFD.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 17,389,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_35FC8304F747](/claim/clm_35FC8304F747.md) | [clm_57623C792BC3](/claim/clm_57623C792BC3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 92,427,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_EBBD764A8BF3](/claim/clm_EBBD764A8BF3.md) | [clm_750B5DA0FE51](/claim/clm_750B5DA0FE51.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 2,456,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_08AC6F344E17](/claim/clm_08AC6F344E17.md) | [clm_784E3697A6A8](/claim/clm_784E3697A6A8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,201,000,000 United States dollar | valid 2025-03-31 to 2025-06-30 | conf 0.95 | superseded | superseded_by [clm_BC0F7635AE7E](/claim/clm_BC0F7635AE7E.md) | [clm_C316438CD5B0](/claim/clm_C316438CD5B0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,029,312,023 shares | valid 2025-02-06 to 2025-04-17 | conf 0.95 | superseded | superseded_by [clm_42F9567D36B6](/claim/clm_42F9567D36B6.md) | [clm_D30764FFE593](/claim/clm_D30764FFE593.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 10,346,000,000 United States dollar | valid 2024-12-31 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_544A85081CFD](/claim/clm_544A85081CFD.md) | [clm_0EF8BDD4B8BF](/claim/clm_0EF8BDD4B8BF.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 92,603,000,000 United States dollar | valid 2024-12-31 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_750B5DA0FE51](/claim/clm_750B5DA0FE51.md) | [clm_28801CE10258](/claim/clm_28801CE10258.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 48,300,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_BB9F55DFC7A5](/claim/clm_BB9F55DFC7A5.md) | [clm_78596CC18E60](/claim/clm_78596CC18E60.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 16,335,000,000 United States dollar | valid 2024-12-31 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_57623C792BC3](/claim/clm_57623C792BC3.md) | [clm_86CA286F16F8](/claim/clm_86CA286F16F8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | -8,948,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_52D44073C808](/claim/clm_52D44073C808.md) | [clm_93176D9F8458](/claim/clm_93176D9F8458.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 11,159,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_1D1D9926921B](/claim/clm_1D1D9926921B.md) | [clm_CC290D20ACB7](/claim/clm_CC290D20ACB7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,028,176,674 shares | valid 2024-10-24 to 2025-02-06 | conf 0.95 | superseded | superseded_by [clm_D30764FFE593](/claim/clm_D30764FFE593.md) | [clm_BA7A9DBB64EB](/claim/clm_BA7A9DBB64EB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 93,670,000,000 United States dollar | valid 2024-09-30 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_28801CE10258](/claim/clm_28801CE10258.md) | [clm_42EA14C3C2C1](/claim/clm_42EA14C3C2C1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 17,142,000,000 United States dollar | valid 2024-09-30 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_86CA286F16F8](/claim/clm_86CA286F16F8.md) | [clm_7820F77B3C4C](/claim/clm_7820F77B3C4C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 7,890,000,000 United States dollar | valid 2024-09-30 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_0EF8BDD4B8BF](/claim/clm_0EF8BDD4B8BF.md) | [clm_A709A72CBB2D](/claim/clm_A709A72CBB2D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,374,000,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_521ADD71267C](/claim/clm_521ADD71267C.md) | [clm_D5943AFEC8DF](/claim/clm_D5943AFEC8DF.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,892,000,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_C316438CD5B0](/claim/clm_C316438CD5B0.md) | [clm_ED30B6615116](/claim/clm_ED30B6615116.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,211,000,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_784E3697A6A8](/claim/clm_784E3697A6A8.md) | [clm_EEAF18DC3347](/claim/clm_EEAF18DC3347.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,027,395,178 shares | valid 2024-07-19 to 2024-10-24 | conf 0.95 | superseded | superseded_by [clm_BA7A9DBB64EB](/claim/clm_BA7A9DBB64EB.md) | [clm_C54C82499A4C](/claim/clm_C54C82499A4C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 12,201,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_ED30B6615116](/claim/clm_ED30B6615116.md) | [clm_0C0D23505909](/claim/clm_0C0D23505909.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,899,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_D5943AFEC8DF](/claim/clm_D5943AFEC8DF.md) | [clm_505BDAA1FD80](/claim/clm_505BDAA1FD80.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,680,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_EEAF18DC3347](/claim/clm_EEAF18DC3347.md) | [clm_52FD14B76A9C](/claim/clm_52FD14B76A9C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 94,646,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_42EA14C3C2C1](/claim/clm_42EA14C3C2C1.md) | [clm_790C721B41A2](/claim/clm_790C721B41A2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 6,293,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_A709A72CBB2D](/claim/clm_A709A72CBB2D.md) | [clm_A0228A94CF34](/claim/clm_A0228A94CF34.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 17,015,000,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_7820F77B3C4C](/claim/clm_7820F77B3C4C.md) | [clm_C11E87824631](/claim/clm_C11E87824631.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,027,100,096 shares | valid 2024-04-18 to 2024-07-19 | conf 0.95 | superseded | superseded_by [clm_C54C82499A4C](/claim/clm_C54C82499A4C.md) | [clm_70CEDDA7AB48](/claim/clm_70CEDDA7AB48.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | chair | Christopher S. Boerner, Ph.D | valid 2024-04-01 to present | conf 0.95 | valid | [clm_62358F2F8937](/claim/clm_62358F2F8937.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | -11,911,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_52FD14B76A9C](/claim/clm_52FD14B76A9C.md) | [clm_051BF490BBD5](/claim/clm_051BF490BBD5.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 99,031,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_790C721B41A2](/claim/clm_790C721B41A2.md) | [clm_3CB5FFCF4FD6](/claim/clm_3CB5FFCF4FD6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 16,490,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_C11E87824631](/claim/clm_C11E87824631.md) | [clm_5A393631CB0B](/claim/clm_5A393631CB0B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,865,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_0C0D23505909](/claim/clm_0C0D23505909.md) | [clm_8679C4DC1004](/claim/clm_8679C4DC1004.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,695,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_505BDAA1FD80](/claim/clm_505BDAA1FD80.md) | [clm_F20B9ABE4C44](/claim/clm_F20B9ABE4C44.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 9,330,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_A0228A94CF34](/claim/clm_A0228A94CF34.md) | [clm_FA0954778351](/claim/clm_FA0954778351.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,022,193,411 shares | valid 2024-02-06 to 2024-04-18 | conf 0.95 | superseded | superseded_by [clm_70CEDDA7AB48](/claim/clm_70CEDDA7AB48.md) | [clm_961777FB557E](/claim/clm_961777FB557E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 45,006,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_78596CC18E60](/claim/clm_78596CC18E60.md) | [clm_2A5DAEAFCF0E](/claim/clm_2A5DAEAFCF0E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 11,464,000,000 United States dollar | valid 2023-12-31 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_FA0954778351](/claim/clm_FA0954778351.md) | [clm_4C220C0862B3](/claim/clm_4C220C0862B3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 9,299,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_CC290D20ACB7](/claim/clm_CC290D20ACB7.md) | [clm_5D4F25142B06](/claim/clm_5D4F25142B06.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 29,430,000,000 United States dollar | valid 2023-12-31 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_5A393631CB0B](/claim/clm_5A393631CB0B.md) | [clm_A14633ABFE56](/claim/clm_A14633ABFE56.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 95,159,000,000 United States dollar | valid 2023-12-31 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_3CB5FFCF4FD6](/claim/clm_3CB5FFCF4FD6.md) | [clm_B19C8515F7D0](/claim/clm_B19C8515F7D0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 8,025,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_93176D9F8458](/claim/clm_93176D9F8458.md) | [clm_D99EB80D0E65](/claim/clm_D99EB80D0E65.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | ceo | Christopher S. Boerner, Ph.D | valid 2023-11-01 to present | conf 0.95 | valid | [clm_FF61856A3386](/claim/clm_FF61856A3386.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,034,757,742 shares | valid 2023-10-20 to 2024-02-06 | conf 0.95 | superseded | superseded_by [clm_961777FB557E](/claim/clm_961777FB557E.md) | [clm_BA7DB48653DB](/claim/clm_BA7DB48653DB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 10,966,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_8679C4DC1004](/claim/clm_8679C4DC1004.md) | [clm_2D8B38C2D603](/claim/clm_2D8B38C2D603.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,242,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_F20B9ABE4C44](/claim/clm_F20B9ABE4C44.md) | [clm_3B07EC588400](/claim/clm_3B07EC588400.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 28,998,000,000 United States dollar | valid 2023-09-30 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_A14633ABFE56](/claim/clm_A14633ABFE56.md) | [clm_5330732B079F](/claim/clm_5330732B079F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,928,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_051BF490BBD5](/claim/clm_051BF490BBD5.md) | [clm_957BE8C6699C](/claim/clm_957BE8C6699C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 91,263,000,000 United States dollar | valid 2023-09-30 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_B19C8515F7D0](/claim/clm_B19C8515F7D0.md) | [clm_E52279CD3AD4](/claim/clm_E52279CD3AD4.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 7,514,000,000 United States dollar | valid 2023-09-30 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_4C220C0862B3](/claim/clm_4C220C0862B3.md) | [clm_F5D4FDEA17A2](/claim/clm_F5D4FDEA17A2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,089,102,921 shares | valid 2023-07-20 to 2023-10-20 | conf 0.95 | superseded | superseded_by [clm_BA7DB48653DB](/claim/clm_BA7DB48653DB.md) | [clm_14E3456699D6](/claim/clm_14E3456699D6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,258,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_3B07EC588400](/claim/clm_3B07EC588400.md) | [clm_3EAB2E029B2D](/claim/clm_3EAB2E029B2D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 31,973,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_5330732B079F](/claim/clm_5330732B079F.md) | [clm_6B4C0EC2CB0D](/claim/clm_6B4C0EC2CB0D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,226,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_2D8B38C2D603](/claim/clm_2D8B38C2D603.md) | [clm_C21A07FB73A6](/claim/clm_C21A07FB73A6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 8,372,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_F5D4FDEA17A2](/claim/clm_F5D4FDEA17A2.md) | [clm_F36D80DAA8A1](/claim/clm_F36D80DAA8A1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 2,073,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_957BE8C6699C](/claim/clm_957BE8C6699C.md) | [clm_FE7837E61B5C](/claim/clm_FE7837E61B5C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 93,489,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_E52279CD3AD4](/claim/clm_E52279CD3AD4.md) | [clm_FF007609C791](/claim/clm_FF007609C791.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,100,847,138 shares | valid 2023-04-20 to 2023-07-20 | conf 0.95 | superseded | superseded_by [clm_14E3456699D6](/claim/clm_14E3456699D6.md) | [clm_5DE655C66164](/claim/clm_5DE655C66164.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 31,824,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_6B4C0EC2CB0D](/claim/clm_6B4C0EC2CB0D.md) | [clm_138C33E2F142](/claim/clm_138C33E2F142.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 8,995,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_F36D80DAA8A1](/claim/clm_F36D80DAA8A1.md) | [clm_30E73DC7BEE0](/claim/clm_30E73DC7BEE0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 2,262,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_FE7837E61B5C](/claim/clm_FE7837E61B5C.md) | [clm_44CF08290E15](/claim/clm_44CF08290E15.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 94,281,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_FF007609C791](/claim/clm_FF007609C791.md) | [clm_882076DBB5AA](/claim/clm_882076DBB5AA.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,337,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_C21A07FB73A6](/claim/clm_C21A07FB73A6.md) | [clm_D93AB25093EB](/claim/clm_D93AB25093EB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,321,000,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_3EAB2E029B2D](/claim/clm_3EAB2E029B2D.md) | [clm_EAC3E9BA1AAF](/claim/clm_EAC3E9BA1AAF.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,098,775,978 shares | valid 2023-02-07 to 2023-04-20 | conf 0.95 | superseded | superseded_by [clm_5DE655C66164](/claim/clm_5DE655C66164.md) | [clm_89F8AB78889B](/claim/clm_89F8AB78889B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 31,061,000,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_138C33E2F142](/claim/clm_138C33E2F142.md) | [clm_06609FC4D334](/claim/clm_06609FC4D334.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 6,327,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_D99EB80D0E65](/claim/clm_D99EB80D0E65.md) | [clm_6ACDA9562DBE](/claim/clm_6ACDA9562DBE.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 9,509,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_5D4F25142B06](/claim/clm_5D4F25142B06.md) | [clm_89EE8CD69449](/claim/clm_89EE8CD69449.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 46,159,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_2A5DAEAFCF0E](/claim/clm_2A5DAEAFCF0E.md) | [clm_918266837860](/claim/clm_918266837860.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 96,820,000,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_882076DBB5AA](/claim/clm_882076DBB5AA.md) | [clm_C58FBFAF2EB4](/claim/clm_C58FBFAF2EB4.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 9,123,000,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_30E73DC7BEE0](/claim/clm_30E73DC7BEE0.md) | [clm_CA5F3EDC2A0A](/claim/clm_CA5F3EDC2A0A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,126,160,347 shares | valid 2022-10-14 to 2023-02-07 | conf 0.95 | superseded | superseded_by [clm_89F8AB78889B](/claim/clm_89F8AB78889B.md) | [clm_FE0F3F8AA345](/claim/clm_FE0F3F8AA345.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,418,000,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_EAC3E9BA1AAF](/claim/clm_EAC3E9BA1AAF.md) | [clm_0295F3B65E36](/claim/clm_0295F3B65E36.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 7,734,000,000 United States dollar | valid 2022-09-30 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_CA5F3EDC2A0A](/claim/clm_CA5F3EDC2A0A.md) | [clm_75FC4B8D08CA](/claim/clm_75FC4B8D08CA.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,606,000,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_44CF08290E15](/claim/clm_44CF08290E15.md) | [clm_87352964FDF2](/claim/clm_87352964FDF2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,218,000,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_D93AB25093EB](/claim/clm_D93AB25093EB.md) | [clm_9D4962A5216A](/claim/clm_9D4962A5216A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 98,196,000,000 United States dollar | valid 2022-09-30 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_C58FBFAF2EB4](/claim/clm_C58FBFAF2EB4.md) | [clm_DED849B2AB45](/claim/clm_DED849B2AB45.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 32,671,000,000 United States dollar | valid 2022-09-30 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_06609FC4D334](/claim/clm_06609FC4D334.md) | [clm_EB64E45B46F0](/claim/clm_EB64E45B46F0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,135,255,158 shares | valid 2022-07-15 to 2022-10-14 | conf 0.95 | superseded | superseded_by [clm_FE0F3F8AA345](/claim/clm_FE0F3F8AA345.md) | [clm_12081EE810AD](/claim/clm_12081EE810AD.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 10,750,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_75FC4B8D08CA](/claim/clm_75FC4B8D08CA.md) | [clm_4956C44116CA](/claim/clm_4956C44116CA.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,421,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_87352964FDF2](/claim/clm_87352964FDF2.md) | [clm_5C4983FE28D2](/claim/clm_5C4983FE28D2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 32,600,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_EB64E45B46F0](/claim/clm_EB64E45B46F0.md) | [clm_7AA355613632](/claim/clm_7AA355613632.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,321,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_0295F3B65E36](/claim/clm_0295F3B65E36.md) | [clm_8C160359CC75](/claim/clm_8C160359CC75.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 100,357,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_DED849B2AB45](/claim/clm_DED849B2AB45.md) | [clm_B6B6B5AD6907](/claim/clm_B6B6B5AD6907.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,887,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_9D4962A5216A](/claim/clm_9D4962A5216A.md) | [clm_D5D7ABA783AD](/claim/clm_D5D7ABA783AD.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 31,580,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_7AA355613632](/claim/clm_7AA355613632.md) | [clm_1A4A9B63691A](/claim/clm_1A4A9B63691A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,260,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_8C160359CC75](/claim/clm_8C160359CC75.md) | [clm_2653771A828C](/claim/clm_2653771A828C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,129,064,271 shares | valid 2022-03-31 to 2022-07-15 | conf 0.95 | superseded | superseded_by [clm_12081EE810AD](/claim/clm_12081EE810AD.md) | [clm_5A111C1886F6](/claim/clm_5A111C1886F6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 12,369,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_4956C44116CA](/claim/clm_4956C44116CA.md) | [clm_6EEE9A4C63D1](/claim/clm_6EEE9A4C63D1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,278,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_5C4983FE28D2](/claim/clm_5C4983FE28D2.md) | [clm_78429352030D](/claim/clm_78429352030D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 103,034,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_B6B6B5AD6907](/claim/clm_B6B6B5AD6907.md) | [clm_9BF64F4F2EFB](/claim/clm_9BF64F4F2EFB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,648,000,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_D5D7ABA783AD](/claim/clm_D5D7ABA783AD.md) | [clm_D79D783840A8](/claim/clm_D79D783840A8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,179,712,820 shares | valid 2022-02-01 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_5A111C1886F6](/claim/clm_5A111C1886F6.md) | [clm_4C917B021977](/claim/clm_4C917B021977.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 6,994,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_6ACDA9562DBE](/claim/clm_6ACDA9562DBE.md) | [clm_05937AB12257](/claim/clm_05937AB12257.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 109,314,000,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_9BF64F4F2EFB](/claim/clm_9BF64F4F2EFB.md) | [clm_06C3B1DD4C8B](/claim/clm_06C3B1DD4C8B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 11,354,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_89EE8CD69449](/claim/clm_89EE8CD69449.md) | [clm_65C9EBE9DAD1](/claim/clm_65C9EBE9DAD1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 46,385,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_918266837860](/claim/clm_918266837860.md) | [clm_7C79E3FC9739](/claim/clm_7C79E3FC9739.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 35,946,000,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_1A4A9B63691A](/claim/clm_1A4A9B63691A.md) | [clm_A053AA50D3D6](/claim/clm_A053AA50D3D6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 13,979,000,000 United States dollar | valid 2021-12-31 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_6EEE9A4C63D1](/claim/clm_6EEE9A4C63D1.md) | [clm_A4D1B1BB0C75](/claim/clm_A4D1B1BB0C75.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 110,893,000,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_06C3B1DD4C8B](/claim/clm_06C3B1DD4C8B.md) | [clm_0BB257BBD468](/claim/clm_0BB257BBD468.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 3,251,000,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_2653771A828C](/claim/clm_2653771A828C.md) | [clm_0FC04F2EC1D4](/claim/clm_0FC04F2EC1D4.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 37,213,000,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_A053AA50D3D6](/claim/clm_A053AA50D3D6.md) | [clm_2C7D852A5EC8](/claim/clm_2C7D852A5EC8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,624,000,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_D79D783840A8](/claim/clm_D79D783840A8.md) | [clm_3ECFD6AA2B23](/claim/clm_3ECFD6AA2B23.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 13,540,000,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_A4D1B1BB0C75](/claim/clm_A4D1B1BB0C75.md) | [clm_684FAEE046F2](/claim/clm_684FAEE046F2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,546,000,000 United States dollar | valid 2021-09-30 to 2022-03-31 | conf 0.95 | superseded | superseded_by [clm_78429352030D](/claim/clm_78429352030D.md) | [clm_73511A037590](/claim/clm_73511A037590.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,219,644,935 shares | valid 2021-09-30 to 2022-02-01 | conf 0.95 | superseded | superseded_by [clm_4C917B021977](/claim/clm_4C917B021977.md) | [clm_CBCD1ADA12BB](/claim/clm_CBCD1ADA12BB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,055,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_73511A037590](/claim/clm_73511A037590.md) | [clm_277248086123](/claim/clm_277248086123.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 110,797,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_0BB257BBD468](/claim/clm_0BB257BBD468.md) | [clm_2F273A18E9C9](/claim/clm_2F273A18E9C9.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 11,024,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_684FAEE046F2](/claim/clm_684FAEE046F2.md) | [clm_4E5FE51C0655](/claim/clm_4E5FE51C0655.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 3,271,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_0FC04F2EC1D4](/claim/clm_0FC04F2EC1D4.md) | [clm_5EB4A92B130D](/claim/clm_5EB4A92B130D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,222,113,553 shares | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_CBCD1ADA12BB](/claim/clm_CBCD1ADA12BB.md) | [clm_6822ABA2EFFD](/claim/clm_6822ABA2EFFD.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,703,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_3ECFD6AA2B23](/claim/clm_3ECFD6AA2B23.md) | [clm_AE7B1C2AA687](/claim/clm_AE7B1C2AA687.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 36,808,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_2C7D852A5EC8](/claim/clm_2C7D852A5EC8.md) | [clm_ECFAB0E9DCCB](/claim/clm_ECFAB0E9DCCB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 10,982,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_4E5FE51C0655](/claim/clm_4E5FE51C0655.md) | [clm_5027DD4D5A87](/claim/clm_5027DD4D5A87.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 112,435,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_2F273A18E9C9](/claim/clm_2F273A18E9C9.md) | [clm_51C303404284](/claim/clm_51C303404284.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 37,605,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_ECFAB0E9DCCB](/claim/clm_ECFAB0E9DCCB.md) | [clm_8639E1E30F7B](/claim/clm_8639E1E30F7B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 2,021,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_277248086123](/claim/clm_277248086123.md) | [clm_866149C707DE](/claim/clm_866149C707DE.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 11,073,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_AE7B1C2AA687](/claim/clm_AE7B1C2AA687.md) | [clm_90167993F3AC](/claim/clm_90167993F3AC.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,225,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_5EB4A92B130D](/claim/clm_5EB4A92B130D.md) | [clm_A28CB9F163E6](/claim/clm_A28CB9F163E6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,232,843,755 shares | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_6822ABA2EFFD](/claim/clm_6822ABA2EFFD.md) | [clm_D0D1E43C143B](/claim/clm_D0D1E43C143B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,240,475,153 shares | valid 2021-02-01 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_D0D1E43C143B](/claim/clm_D0D1E43C143B.md) | [clm_254854D61B35](/claim/clm_254854D61B35.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 14,546,000,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_5027DD4D5A87](/claim/clm_5027DD4D5A87.md) | [clm_0B8693A32C26](/claim/clm_0B8693A32C26.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 42,518,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_7C79E3FC9739](/claim/clm_7C79E3FC9739.md) | [clm_1987D0BBF44A](/claim/clm_1987D0BBF44A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | -9,015,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_05937AB12257](/claim/clm_05937AB12257.md) | [clm_57F7E30CC5E5](/claim/clm_57F7E30CC5E5.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 37,822,000,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_8639E1E30F7B](/claim/clm_8639E1E30F7B.md) | [clm_65A170B22957](/claim/clm_65A170B22957.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 118,481,000,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_51C303404284](/claim/clm_51C303404284.md) | [clm_A01742400231](/claim/clm_A01742400231.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 11,143,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_65C9EBE9DAD1](/claim/clm_65C9EBE9DAD1.md) | [clm_F9273E2418F6](/claim/clm_F9273E2418F6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,259,751,518 shares | valid 2020-09-30 to 2021-02-01 | conf 0.95 | superseded | superseded_by [clm_254854D61B35](/claim/clm_254854D61B35.md) | [clm_43AB021CE223](/claim/clm_43AB021CE223.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000279/0000014272-20-000279-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 50,230,000,000 United States dollar | valid 2020-09-30 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_65A170B22957](/claim/clm_65A170B22957.md) | [clm_69DE89B77CE2](/claim/clm_69DE89B77CE2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 19,435,000,000 United States dollar | valid 2020-09-30 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_0B8693A32C26](/claim/clm_0B8693A32C26.md) | [clm_884B8780B580](/claim/clm_884B8780B580.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 125,536,000,000 United States dollar | valid 2020-09-30 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_A01742400231](/claim/clm_A01742400231.md) | [clm_8AF7E2A90164](/claim/clm_8AF7E2A90164.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 10,540,000,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_90167993F3AC](/claim/clm_90167993F3AC.md) | [clm_DF8AB3989828](/claim/clm_DF8AB3989828.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000279/0000014272-20-000279-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,499,000,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_A28CB9F163E6](/claim/clm_A28CB9F163E6.md) | [clm_DFB52240EC1C](/claim/clm_DFB52240EC1C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000279/0000014272-20-000279-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,872,000,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_866149C707DE](/claim/clm_866149C707DE.md) | [clm_EAD2E09DD3D8](/claim/clm_EAD2E09DD3D8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000279/0000014272-20-000279-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | -85,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_EAD2E09DD3D8](/claim/clm_EAD2E09DD3D8.md) | [clm_0C6130021C29](/claim/clm_0C6130021C29.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000229/0000014272-20-000229-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 10,129,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_DF8AB3989828](/claim/clm_DF8AB3989828.md) | [clm_1480298B3F56](/claim/clm_1480298B3F56.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000229/0000014272-20-000229-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 128,076,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_8AF7E2A90164](/claim/clm_8AF7E2A90164.md) | [clm_1DAFE43C35A4](/claim/clm_1DAFE43C35A4.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,253,934,635 shares | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_43AB021CE223](/claim/clm_43AB021CE223.md) | [clm_2A6910A4AE14](/claim/clm_2A6910A4AE14.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000229/0000014272-20-000229-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 49,160,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_69DE89B77CE2](/claim/clm_69DE89B77CE2.md) | [clm_59F5F248270E](/claim/clm_59F5F248270E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 19,934,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_884B8780B580](/claim/clm_884B8780B580.md) | [clm_A721004E4D01](/claim/clm_A721004E4D01.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,522,000,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_DFB52240EC1C](/claim/clm_DFB52240EC1C.md) | [clm_CE259F6F0F77](/claim/clm_CE259F6F0F77.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000229/0000014272-20-000229-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 49,977,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_59F5F248270E](/claim/clm_59F5F248270E.md) | [clm_11D9A4FE1C1E](/claim/clm_11D9A4FE1C1E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,372,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_CE259F6F0F77](/claim/clm_CE259F6F0F77.md) | [clm_2EA411A55113](/claim/clm_2EA411A55113.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000168/0000014272-20-000168-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 15,817,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_A721004E4D01](/claim/clm_A721004E4D01.md) | [clm_3C9C32E3F722](/claim/clm_3C9C32E3F722.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 129,285,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_1DAFE43C35A4](/claim/clm_1DAFE43C35A4.md) | [clm_4CCF4B9A6223](/claim/clm_4CCF4B9A6223.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,262,689,755 shares | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_2A6910A4AE14](/claim/clm_2A6910A4AE14.md) | [clm_6233ECF4334A](/claim/clm_6233ECF4334A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000168/0000014272-20-000168-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 10,781,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_1480298B3F56](/claim/clm_1480298B3F56.md) | [clm_9C633E980249](/claim/clm_9C633E980249.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000168/0000014272-20-000168-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | -775,000,000 United States dollar | valid 2020-03-31 to 2020-06-30 | conf 0.95 | superseded | superseded_by [clm_0C6130021C29](/claim/clm_0C6130021C29.md) | [clm_A5B3E6D95752](/claim/clm_A5B3E6D95752.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000168/0000014272-20-000168-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 2,257,510,796 shares | valid 2020-02-03 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_6233ECF4334A](/claim/clm_6233ECF4334A.md) | [clm_09C7002CC551](/claim/clm_09C7002CC551.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 51,598,000,000 United States dollar | valid 2019-12-31 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_11D9A4FE1C1E](/claim/clm_11D9A4FE1C1E.md) | [clm_397E1F968A33](/claim/clm_397E1F968A33.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 12,346,000,000 United States dollar | valid 2019-12-31 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_3C9C32E3F722](/claim/clm_3C9C32E3F722.md) | [clm_44F09489928F](/claim/clm_44F09489928F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 26,145,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_1987D0BBF44A](/claim/clm_1987D0BBF44A.md) | [clm_8CDC7F496B1F](/claim/clm_8CDC7F496B1F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 6,148,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_F9273E2418F6](/claim/clm_F9273E2418F6.md) | [clm_9F214679BDA4](/claim/clm_9F214679BDA4.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 129,944,000,000 United States dollar | valid 2019-12-31 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_4CCF4B9A6223](/claim/clm_4CCF4B9A6223.md) | [clm_C1D1EC448AA2](/claim/clm_C1D1EC448AA2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 3,439,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_57F7E30CC5E5](/claim/clm_57F7E30CC5E5.md) | [clm_C8A05222B289](/claim/clm_C8A05222B289.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,382,000,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_2EA411A55113](/claim/clm_2EA411A55113.md) | [clm_223CF07E8DCB](/claim/clm_223CF07E8DCB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 57,433,000,000 United States dollar | valid 2019-09-30 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_C1D1EC448AA2](/claim/clm_C1D1EC448AA2.md) | [clm_269A6A024BB7](/claim/clm_269A6A024BB7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,629,284,798 shares | valid 2019-09-30 to 2020-02-03 | conf 0.95 | superseded | superseded_by [clm_09C7002CC551](/claim/clm_09C7002CC551.md) | [clm_6DD303AFB74A](/claim/clm_6DD303AFB74A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 17,754,000,000 United States dollar | valid 2019-09-30 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_397E1F968A33](/claim/clm_397E1F968A33.md) | [clm_8D917D55CCA8](/claim/clm_8D917D55CCA8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,353,000,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_A5B3E6D95752](/claim/clm_A5B3E6D95752.md) | [clm_9782F540E4D7](/claim/clm_9782F540E4D7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 30,489,000,000 United States dollar | valid 2019-09-30 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_44F09489928F](/claim/clm_44F09489928F.md) | [clm_F33683F3C5F0](/claim/clm_F33683F3C5F0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 6,007,000,000 United States dollar | valid 2019-09-30 to 2020-03-31 | conf 0.95 | superseded | superseded_by [clm_9C633E980249](/claim/clm_9C633E980249.md) | [clm_F9A04C9D9D15](/claim/clm_F9A04C9D9D15.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,328,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_223CF07E8DCB](/claim/clm_223CF07E8DCB.md) | [clm_194E6D7B5322](/claim/clm_194E6D7B5322.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,432,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_9782F540E4D7](/claim/clm_9782F540E4D7.md) | [clm_3E7F99B36E7F](/claim/clm_3E7F99B36E7F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 16,151,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_8D917D55CCA8](/claim/clm_8D917D55CCA8.md) | [clm_4614511A1408](/claim/clm_4614511A1408.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,635,766,530 shares | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_6DD303AFB74A](/claim/clm_6DD303AFB74A.md) | [clm_6E714A180173](/claim/clm_6E714A180173.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 55,163,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_269A6A024BB7](/claim/clm_269A6A024BB7.md) | [clm_8B3E326E2E0A](/claim/clm_8B3E326E2E0A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 6,273,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_F9A04C9D9D15](/claim/clm_F9A04C9D9D15.md) | [clm_A94D041424B3](/claim/clm_A94D041424B3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 28,404,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_F33683F3C5F0](/claim/clm_F33683F3C5F0.md) | [clm_D1B939B07F88](/claim/clm_D1B939B07F88.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,317,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_4614511A1408](/claim/clm_4614511A1408.md) | [clm_4C3A6CBEE24D](/claim/clm_4C3A6CBEE24D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,710,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_3E7F99B36E7F](/claim/clm_3E7F99B36E7F.md) | [clm_719B72CC321F](/claim/clm_719B72CC321F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,920,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_A94D041424B3](/claim/clm_A94D041424B3.md) | [clm_72FA5EB78BF3](/claim/clm_72FA5EB78BF3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,351,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_194E6D7B5322](/claim/clm_194E6D7B5322.md) | [clm_8F9CDE701651](/claim/clm_8F9CDE701651.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 34,834,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_8B3E326E2E0A](/claim/clm_8B3E326E2E0A.md) | [clm_99721B72EBF7](/claim/clm_99721B72EBF7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,635,705,782 shares | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_6E714A180173](/claim/clm_6E714A180173.md) | [clm_B296621709ED](/claim/clm_B296621709ED.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 7,335,000,000 United States dollar | valid 2019-03-31 to 2019-06-30 | conf 0.95 | superseded | superseded_by [clm_D1B939B07F88](/claim/clm_D1B939B07F88.md) | [clm_CE2CD25F73DE](/claim/clm_CE2CD25F73DE.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,632,675,877 shares | valid 2019-02-01 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_B296621709ED](/claim/clm_B296621709ED.md) | [clm_BCA073817AB3](/claim/clm_BCA073817AB3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 34,986,000,000 United States dollar | valid 2018-12-31 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_99721B72EBF7](/claim/clm_99721B72EBF7.md) | [clm_0F8FF0DB46E7](/claim/clm_0F8FF0DB46E7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 6,911,000,000 United States dollar | valid 2018-12-31 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_CE2CD25F73DE](/claim/clm_CE2CD25F73DE.md) | [clm_30A3E0BC16D5](/claim/clm_30A3E0BC16D5.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 4,920,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_C8A05222B289](/claim/clm_C8A05222B289.md) | [clm_64236E065BCB](/claim/clm_64236E065BCB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,031,000,000 United States dollar | valid 2018-12-31 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_4C3A6CBEE24D](/claim/clm_4C3A6CBEE24D.md) | [clm_6998F49CC4C9](/claim/clm_6998F49CC4C9.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 6,345,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_9F214679BDA4](/claim/clm_9F214679BDA4.md) | [clm_7E477650E516](/claim/clm_7E477650E516.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 22,561,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_8CDC7F496B1F](/claim/clm_8CDC7F496B1F.md) | [clm_ADD516471339](/claim/clm_ADD516471339.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,901,000,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_719B72CC321F](/claim/clm_719B72CC321F.md) | [clm_01F359D6771D](/claim/clm_01F359D6771D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000197/0000014272-18-000197-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,734,000,000 United States dollar | valid 2018-09-30 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_0F8FF0DB46E7](/claim/clm_0F8FF0DB46E7.md) | [clm_0283BB48D5DC](/claim/clm_0283BB48D5DC.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 13,750,000,000 United States dollar | valid 2018-09-30 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_6998F49CC4C9](/claim/clm_6998F49CC4C9.md) | [clm_16267AA5D734](/claim/clm_16267AA5D734.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,280,000,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_8F9CDE701651](/claim/clm_8F9CDE701651.md) | [clm_45DDDCF11BF8](/claim/clm_45DDDCF11BF8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000197/0000014272-18-000197-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,632,198,774 shares | valid 2018-09-30 to 2019-02-01 | conf 0.95 | superseded | superseded_by [clm_BCA073817AB3](/claim/clm_BCA073817AB3.md) | [clm_644B8C483B86](/claim/clm_644B8C483B86.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000197/0000014272-18-000197-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,691,000,000 United States dollar | valid 2018-09-30 to 2019-03-31 | conf 0.95 | superseded | superseded_by [clm_72FA5EB78BF3](/claim/clm_72FA5EB78BF3.md) | [clm_94497E05D84C](/claim/clm_94497E05D84C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 5,408,000,000 United States dollar | valid 2018-09-30 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_30A3E0BC16D5](/claim/clm_30A3E0BC16D5.md) | [clm_9CC0E50BC241](/claim/clm_9CC0E50BC241.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,631,876,909 shares | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_644B8C483B86](/claim/clm_644B8C483B86.md) | [clm_0192CB6E8E4B](/claim/clm_0192CB6E8E4B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000160/0000014272-18-000160-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 12,418,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_16267AA5D734](/claim/clm_16267AA5D734.md) | [clm_056F9B84FFD1](/claim/clm_056F9B84FFD1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,704,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_94497E05D84C](/claim/clm_94497E05D84C.md) | [clm_1C9B88505F80](/claim/clm_1C9B88505F80.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 32,641,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_0283BB48D5DC](/claim/clm_0283BB48D5DC.md) | [clm_43FB16AECDDD](/claim/clm_43FB16AECDDD.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,435,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_45DDDCF11BF8](/claim/clm_45DDDCF11BF8.md) | [clm_711CD08A7AE6](/claim/clm_711CD08A7AE6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000160/0000014272-18-000160-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 373,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_01F359D6771D](/claim/clm_01F359D6771D.md) | [clm_865C2D20072F](/claim/clm_865C2D20072F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000160/0000014272-18-000160-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 4,999,000,000 United States dollar | valid 2018-06-30 to 2018-09-30 | conf 0.95 | superseded | superseded_by [clm_9CC0E50BC241](/claim/clm_9CC0E50BC241.md) | [clm_CC7BB12DEC8A](/claim/clm_CC7BB12DEC8A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,634,538,458 shares | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_0192CB6E8E4B](/claim/clm_0192CB6E8E4B.md) | [clm_0E4D8DE1C7EA](/claim/clm_0E4D8DE1C7EA.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000117/0000014272-18-000117-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 5,342,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_CC7BB12DEC8A](/claim/clm_CC7BB12DEC8A.md) | [clm_2573A3BBCBF5](/claim/clm_2573A3BBCBF5.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,486,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_865C2D20072F](/claim/clm_865C2D20072F.md) | [clm_99C117669E0D](/claim/clm_99C117669E0D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000117/0000014272-18-000117-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 12,906,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_056F9B84FFD1](/claim/clm_056F9B84FFD1.md) | [clm_AD378F8920A1](/claim/clm_AD378F8920A1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,250,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_711CD08A7AE6](/claim/clm_711CD08A7AE6.md) | [clm_CE50CA7EBC72](/claim/clm_CE50CA7EBC72.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000117/0000014272-18-000117-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,193,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_1C9B88505F80](/claim/clm_1C9B88505F80.md) | [clm_EA4AEE2CC782](/claim/clm_EA4AEE2CC782.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,083,000,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_43FB16AECDDD](/claim/clm_43FB16AECDDD.md) | [clm_FE1738896D5E](/claim/clm_FE1738896D5E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,632,582,502 shares | valid 2018-02-01 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_0E4D8DE1C7EA](/claim/clm_0E4D8DE1C7EA.md) | [clm_18C230DCFBC6](/claim/clm_18C230DCFBC6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,551,000,000 United States dollar | valid 2017-12-31 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_FE1738896D5E](/claim/clm_FE1738896D5E.md) | [clm_23E53864B4D3](/claim/clm_23E53864B4D3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 6,411,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_7E477650E516](/claim/clm_7E477650E516.md) | [clm_49AB8FAB8853](/claim/clm_49AB8FAB8853.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 5,421,000,000 United States dollar | valid 2017-12-31 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_2573A3BBCBF5](/claim/clm_2573A3BBCBF5.md) | [clm_4B9607419F92](/claim/clm_4B9607419F92.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 1,007,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_64236E065BCB](/claim/clm_64236E065BCB.md) | [clm_73D0FA4C51CF](/claim/clm_73D0FA4C51CF.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 11,741,000,000 United States dollar | valid 2017-12-31 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_AD378F8920A1](/claim/clm_AD378F8920A1.md) | [clm_DA2627C3AE6A](/claim/clm_DA2627C3AE6A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 20,776,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_ADD516471339](/claim/clm_ADD516471339.md) | [clm_F2061DAE77B3](/claim/clm_F2061DAE77B3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,977,000,000 United States dollar | valid 2017-09-30 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_23E53864B4D3](/claim/clm_23E53864B4D3.md) | [clm_0138C65261E5](/claim/clm_0138C65261E5.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,636,699,696 shares | valid 2017-09-30 to 2018-02-01 | conf 0.95 | superseded | superseded_by [clm_18C230DCFBC6](/claim/clm_18C230DCFBC6.md) | [clm_36A1F4B8C3C8](/claim/clm_36A1F4B8C3C8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000195/0000014272-17-000195-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,254,000,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_EA4AEE2CC782](/claim/clm_EA4AEE2CC782.md) | [clm_3FA32606AD67](/claim/clm_3FA32606AD67.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000195/0000014272-17-000195-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,543,000,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_CE50CA7EBC72](/claim/clm_CE50CA7EBC72.md) | [clm_7CA800414703](/claim/clm_7CA800414703.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000195/0000014272-17-000195-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 845,000,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_99C117669E0D](/claim/clm_99C117669E0D.md) | [clm_ADE2F00E4DDB](/claim/clm_ADE2F00E4DDB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000195/0000014272-17-000195-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 4,644,000,000 United States dollar | valid 2017-09-30 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_4B9607419F92](/claim/clm_4B9607419F92.md) | [clm_BAA6A9BFA238](/claim/clm_BAA6A9BFA238.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,914,000,000 United States dollar | valid 2017-09-30 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_DA2627C3AE6A](/claim/clm_DA2627C3AE6A.md) | [clm_DDD45770BE4E](/claim/clm_DDD45770BE4E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,144,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_3FA32606AD67](/claim/clm_3FA32606AD67.md) | [clm_13C469851C8D](/claim/clm_13C469851C8D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000165/0000014272-17-000165-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,821,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_DDD45770BE4E](/claim/clm_DDD45770BE4E.md) | [clm_1592847EAB0A](/claim/clm_1592847EAB0A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,639,926,446 shares | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_36A1F4B8C3C8](/claim/clm_36A1F4B8C3C8.md) | [clm_1EF6874F3B9E](/claim/clm_1EF6874F3B9E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000165/0000014272-17-000165-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 916,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_ADE2F00E4DDB](/claim/clm_ADE2F00E4DDB.md) | [clm_7A1E5B3278B9](/claim/clm_7A1E5B3278B9.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000165/0000014272-17-000165-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 3,470,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_BAA6A9BFA238](/claim/clm_BAA6A9BFA238.md) | [clm_7BA54E495432](/claim/clm_7BA54E495432.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,659,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_7CA800414703](/claim/clm_7CA800414703.md) | [clm_7C9FD51E8911](/claim/clm_7C9FD51E8911.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000165/0000014272-17-000165-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,409,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_0138C65261E5](/claim/clm_0138C65261E5.md) | [clm_DCD3B33FD8BF](/claim/clm_DCD3B33FD8BF.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,288,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_7C9FD51E8911](/claim/clm_7C9FD51E8911.md) | [clm_1CFFBAD49F89](/claim/clm_1CFFBAD49F89.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000132/0000014272-17-000132-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 3,910,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_7BA54E495432](/claim/clm_7BA54E495432.md) | [clm_347D00E298E7](/claim/clm_347D00E298E7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 32,937,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_DCD3B33FD8BF](/claim/clm_DCD3B33FD8BF.md) | [clm_3C926135F3AA](/claim/clm_3C926135F3AA.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,929,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_13C469851C8D](/claim/clm_13C469851C8D.md) | [clm_5F8F7439821E](/claim/clm_5F8F7439821E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000132/0000014272-17-000132-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,535,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_1592847EAB0A](/claim/clm_1592847EAB0A.md) | [clm_7515238AD7A3](/claim/clm_7515238AD7A3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,574,000,000 United States dollar | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_7A1E5B3278B9](/claim/clm_7A1E5B3278B9.md) | [clm_851C1B81A4D2](/claim/clm_851C1B81A4D2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000132/0000014272-17-000132-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,647,434,458 shares | valid 2017-03-31 to 2017-06-30 | conf 0.95 | superseded | superseded_by [clm_1EF6874F3B9E](/claim/clm_1EF6874F3B9E.md) | [clm_8ACD59EA48B0](/claim/clm_8ACD59EA48B0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000132/0000014272-17-000132-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,672,715,340 shares | valid 2017-02-01 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_8ACD59EA48B0](/claim/clm_8ACD59EA48B0.md) | [clm_EE65A79883E4](/claim/clm_EE65A79883E4.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 4,237,000,000 United States dollar | valid 2016-12-31 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_347D00E298E7](/claim/clm_347D00E298E7.md) | [clm_1035AAAB0ABB](/claim/clm_1035AAAB0ABB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 4,457,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_73D0FA4C51CF](/claim/clm_73D0FA4C51CF.md) | [clm_4981ADA710E1](/claim/clm_4981ADA710E1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,707,000,000 United States dollar | valid 2016-12-31 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_3C926135F3AA](/claim/clm_3C926135F3AA.md) | [clm_4F679F70F3C0](/claim/clm_4F679F70F3C0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 19,427,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_F2061DAE77B3](/claim/clm_F2061DAE77B3.md) | [clm_57A579F455C8](/claim/clm_57A579F455C8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 4,940,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_49AB8FAB8853](/claim/clm_49AB8FAB8853.md) | [clm_6393A7B2A9CB](/claim/clm_6393A7B2A9CB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 16,177,000,000 United States dollar | valid 2016-12-31 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_7515238AD7A3](/claim/clm_7515238AD7A3.md) | [clm_7A0A9FB10012](/claim/clm_7A0A9FB10012.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,922,000,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_5F8F7439821E](/claim/clm_5F8F7439821E.md) | [clm_18781A133073](/claim/clm_18781A133073.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000491/0000014272-16-000491-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 3,432,000,000 United States dollar | valid 2016-09-30 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_1035AAAB0ABB](/claim/clm_1035AAAB0ABB.md) | [clm_32AAF035F0A8](/claim/clm_32AAF035F0A8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,671,229,946 shares | valid 2016-09-30 to 2017-02-01 | conf 0.95 | superseded | superseded_by [clm_EE65A79883E4](/claim/clm_EE65A79883E4.md) | [clm_8063757EF4E7](/claim/clm_8063757EF4E7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000491/0000014272-16-000491-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,202,000,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_851C1B81A4D2](/claim/clm_851C1B81A4D2.md) | [clm_986BCF3AD62C](/claim/clm_986BCF3AD62C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000491/0000014272-16-000491-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,138,000,000 United States dollar | valid 2016-09-30 to 2017-03-31 | conf 0.95 | superseded | superseded_by [clm_1CFFBAD49F89](/claim/clm_1CFFBAD49F89.md) | [clm_98768D817D6F](/claim/clm_98768D817D6F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000491/0000014272-16-000491-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,727,000,000 United States dollar | valid 2016-09-30 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_4F679F70F3C0](/claim/clm_4F679F70F3C0.md) | [clm_9BDC1541B164](/claim/clm_9BDC1541B164.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,781,000,000 United States dollar | valid 2016-09-30 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_7A0A9FB10012](/claim/clm_7A0A9FB10012.md) | [clm_ECD179DF015D](/claim/clm_ECD179DF015D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,166,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_986BCF3AD62C](/claim/clm_986BCF3AD62C.md) | [clm_15CE83DC11F7](/claim/clm_15CE83DC11F7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000461/0000014272-16-000461-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,871,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_18781A133073](/claim/clm_18781A133073.md) | [clm_1DD87B004226](/claim/clm_1DD87B004226.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000461/0000014272-16-000461-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,078,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_ECD179DF015D](/claim/clm_ECD179DF015D.md) | [clm_30F9393ADCF1](/claim/clm_30F9393ADCF1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 32,831,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_9BDC1541B164](/claim/clm_9BDC1541B164.md) | [clm_5CC6CD0DCABD](/claim/clm_5CC6CD0DCABD.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 2,934,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_32AAF035F0A8](/claim/clm_32AAF035F0A8.md) | [clm_957363951295](/claim/clm_957363951295.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,266,000,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_98768D817D6F](/claim/clm_98768D817D6F.md) | [clm_978C16624868](/claim/clm_978C16624868.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000461/0000014272-16-000461-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,670,858,535 shares | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_8063757EF4E7](/claim/clm_8063757EF4E7.md) | [clm_B8969CB68765](/claim/clm_B8969CB68765.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000461/0000014272-16-000461-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,551,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_30F9393ADCF1](/claim/clm_30F9393ADCF1.md) | [clm_0B00A3BD5E84](/claim/clm_0B00A3BD5E84.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,195,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_15CE83DC11F7](/claim/clm_15CE83DC11F7.md) | [clm_70E0D16FEF0D](/claim/clm_70E0D16FEF0D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000399/0000014272-16-000399-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,391,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_1DD87B004226](/claim/clm_1DD87B004226.md) | [clm_76DE4FA9E643](/claim/clm_76DE4FA9E643.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000399/0000014272-16-000399-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,669,307,273 shares | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_B8969CB68765](/claim/clm_B8969CB68765.md) | [clm_8EE01557A4E6](/claim/clm_8EE01557A4E6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000399/0000014272-16-000399-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 2,644,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_957363951295](/claim/clm_957363951295.md) | [clm_B8B01A4BE920](/claim/clm_B8B01A4BE920.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,136,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_978C16624868](/claim/clm_978C16624868.md) | [clm_F353300DD7DB](/claim/clm_F353300DD7DB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000399/0000014272-16-000399-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 31,892,000,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_5CC6CD0DCABD](/claim/clm_5CC6CD0DCABD.md) | [clm_F3C80A297662](/claim/clm_F3C80A297662.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,669,459,090 shares | valid 2016-02-01 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_8EE01557A4E6](/claim/clm_8EE01557A4E6.md) | [clm_92668B1A6C2E](/claim/clm_92668B1A6C2E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 5,920,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_6393A7B2A9CB](/claim/clm_6393A7B2A9CB.md) | [clm_0EB21ED2CFE3](/claim/clm_0EB21ED2CFE3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,266,000,000 United States dollar | valid 2015-12-31 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_0B00A3BD5E84](/claim/clm_0B00A3BD5E84.md) | [clm_76099FA48BDF](/claim/clm_76099FA48BDF.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 16,560,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_57A579F455C8](/claim/clm_57A579F455C8.md) | [clm_B192EABF21B6](/claim/clm_B192EABF21B6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 2,385,000,000 United States dollar | valid 2015-12-31 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_B8B01A4BE920](/claim/clm_B8B01A4BE920.md) | [clm_D4314A88ED11](/claim/clm_D4314A88ED11.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 31,748,000,000 United States dollar | valid 2015-12-31 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_F3C80A297662](/claim/clm_F3C80A297662.md) | [clm_DF29D46189B8](/claim/clm_DF29D46189B8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 1,565,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_4981ADA710E1](/claim/clm_4981ADA710E1.md) | [clm_EE77C19D23BB](/claim/clm_EE77C19D23BB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 31,779,000,000 United States dollar | valid 2015-09-30 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_DF29D46189B8](/claim/clm_DF29D46189B8.md) | [clm_3D268281546C](/claim/clm_3D268281546C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,668,286,317 shares | valid 2015-09-30 to 2016-02-01 | conf 0.95 | superseded | superseded_by [clm_92668B1A6C2E](/claim/clm_92668B1A6C2E.md) | [clm_8EB882510175](/claim/clm_8EB882510175.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000235/0000014272-15-000235-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,273,000,000 United States dollar | valid 2015-09-30 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_76099FA48BDF](/claim/clm_76099FA48BDF.md) | [clm_9B6FCBCD9BB0](/claim/clm_9B6FCBCD9BB0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 3,975,000,000 United States dollar | valid 2015-09-30 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_D4314A88ED11](/claim/clm_D4314A88ED11.md) | [clm_B0117C04AB60](/claim/clm_B0117C04AB60.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 706,000,000 United States dollar | valid 2015-09-30 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_70E0D16FEF0D](/claim/clm_70E0D16FEF0D.md) | [clm_C819205D6190](/claim/clm_C819205D6190.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000235/0000014272-15-000235-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,069,000,000 United States dollar | valid 2015-09-30 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_76DE4FA9E643](/claim/clm_76DE4FA9E643.md) | [clm_F94A6EEA38D3](/claim/clm_F94A6EEA38D3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000235/0000014272-15-000235-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,132,000,000 United States dollar | valid 2015-09-30 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_F353300DD7DB](/claim/clm_F353300DD7DB.md) | [clm_FD8FE6AED540](/claim/clm_FD8FE6AED540.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000235/0000014272-15-000235-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,667,502,766 shares | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_8EB882510175](/claim/clm_8EB882510175.md) | [clm_0DDECD3BC6A2](/claim/clm_0DDECD3BC6A2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000212/0000014272-15-000212-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 31,954,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_3D268281546C](/claim/clm_3D268281546C.md) | [clm_64FCE5F5CC75](/claim/clm_64FCE5F5CC75.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,856,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_FD8FE6AED540](/claim/clm_FD8FE6AED540.md) | [clm_6771195A5964](/claim/clm_6771195A5964.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000212/0000014272-15-000212-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | -130,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_C819205D6190](/claim/clm_C819205D6190.md) | [clm_96165F529E51](/claim/clm_96165F529E51.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000212/0000014272-15-000212-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,291,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_9B6FCBCD9BB0](/claim/clm_9B6FCBCD9BB0.md) | [clm_AAF5F66DD904](/claim/clm_AAF5F66DD904.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,163,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_F94A6EEA38D3](/claim/clm_F94A6EEA38D3.md) | [clm_AB1D876445CB](/claim/clm_AB1D876445CB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000212/0000014272-15-000212-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 4,199,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_B0117C04AB60](/claim/clm_B0117C04AB60.md) | [clm_CCE8F02B208C](/claim/clm_CCE8F02B208C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,689,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_AAF5F66DD904](/claim/clm_AAF5F66DD904.md) | [clm_0192022AE328](/claim/clm_0192022AE328.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,041,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_AB1D876445CB](/claim/clm_AB1D876445CB.md) | [clm_1DAC03642CAB](/claim/clm_1DAC03642CAB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000178/0000014272-15-000178-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 6,294,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_CCE8F02B208C](/claim/clm_CCE8F02B208C.md) | [clm_2D49EA7CA617](/claim/clm_2D49EA7CA617.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,016,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_6771195A5964](/claim/clm_6771195A5964.md) | [clm_4FBA1EFF7D90](/claim/clm_4FBA1EFF7D90.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000178/0000014272-15-000178-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,666,974,545 shares | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_0DDECD3BC6A2](/claim/clm_0DDECD3BC6A2.md) | [clm_7ECB754D94B8](/claim/clm_7ECB754D94B8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000178/0000014272-15-000178-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,579,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_64FCE5F5CC75](/claim/clm_64FCE5F5CC75.md) | [clm_9763696C10AA](/claim/clm_9763696C10AA.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,186,000,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_96165F529E51](/claim/clm_96165F529E51.md) | [clm_EB00F078653A](/claim/clm_EB00F078653A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000178/0000014272-15-000178-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,662,118,446 shares | valid 2015-02-02 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_7ECB754D94B8](/claim/clm_7ECB754D94B8.md) | [clm_47A9EEF643F4](/claim/clm_47A9EEF643F4.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 2,004,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_EE77C19D23BB](/claim/clm_EE77C19D23BB.md) | [clm_849DE9DA8A78](/claim/clm_849DE9DA8A78.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,749,000,000 United States dollar | valid 2014-12-31 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_9763696C10AA](/claim/clm_9763696C10AA.md) | [clm_86A59CABE1F2](/claim/clm_86A59CABE1F2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 4,534,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_0EB21ED2CFE3](/claim/clm_0EB21ED2CFE3.md) | [clm_B78350FCAC19](/claim/clm_B78350FCAC19.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 5,571,000,000 United States dollar | valid 2014-12-31 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_2D49EA7CA617](/claim/clm_2D49EA7CA617.md) | [clm_D2BA081EDED0](/claim/clm_D2BA081EDED0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 15,879,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_B192EABF21B6](/claim/clm_B192EABF21B6.md) | [clm_E35D5B28759F](/claim/clm_E35D5B28759F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,852,000,000 United States dollar | valid 2014-12-31 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_0192022AE328](/claim/clm_0192022AE328.md) | [clm_F27D0B683974](/claim/clm_F27D0B683974.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 721,000,000 United States dollar | valid 2014-09-30 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_EB00F078653A](/claim/clm_EB00F078653A.md) | [clm_046118EE4074](/claim/clm_046118EE4074.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000257/0000014272-14-000257-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,658,776,491 shares | valid 2014-09-30 to 2015-02-02 | conf 0.95 | superseded | superseded_by [clm_47A9EEF643F4](/claim/clm_47A9EEF643F4.md) | [clm_0B78835A0141](/claim/clm_0B78835A0141.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000257/0000014272-14-000257-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 4,851,000,000 United States dollar | valid 2014-09-30 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_D2BA081EDED0](/claim/clm_D2BA081EDED0.md) | [clm_11320D01EF6B](/claim/clm_11320D01EF6B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 3,921,000,000 United States dollar | valid 2014-09-30 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_1DAC03642CAB](/claim/clm_1DAC03642CAB.md) | [clm_B93057222A64](/claim/clm_B93057222A64.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000257/0000014272-14-000257-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 983,000,000 United States dollar | valid 2014-09-30 to 2015-03-31 | conf 0.95 | superseded | superseded_by [clm_4FBA1EFF7D90](/claim/clm_4FBA1EFF7D90.md) | [clm_C74D8497C168](/claim/clm_C74D8497C168.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000257/0000014272-14-000257-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,201,000,000 United States dollar | valid 2014-09-30 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_F27D0B683974](/claim/clm_F27D0B683974.md) | [clm_D7BAD79013E2](/claim/clm_D7BAD79013E2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,450,000,000 United States dollar | valid 2014-09-30 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_86A59CABE1F2](/claim/clm_86A59CABE1F2.md) | [clm_DA44714068D4](/claim/clm_DA44714068D4.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,657,904,666 shares | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_0B78835A0141](/claim/clm_0B78835A0141.md) | [clm_099A5E3E5A27](/claim/clm_099A5E3E5A27.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000214/0000014272-14-000214-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 4,282,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_11320D01EF6B](/claim/clm_11320D01EF6B.md) | [clm_7ABFC31A8BB3](/claim/clm_7ABFC31A8BB3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,503,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_DA44714068D4](/claim/clm_DA44714068D4.md) | [clm_95358B86E7F7](/claim/clm_95358B86E7F7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 333,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_046118EE4074](/claim/clm_046118EE4074.md) | [clm_AC6E23B2F9C9](/claim/clm_AC6E23B2F9C9.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000214/0000014272-14-000214-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,416,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_C74D8497C168](/claim/clm_C74D8497C168.md) | [clm_B68B536C52EB](/claim/clm_B68B536C52EB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000214/0000014272-14-000214-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 3,889,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_B93057222A64](/claim/clm_B93057222A64.md) | [clm_C0146E275324](/claim/clm_C0146E275324.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000214/0000014272-14-000214-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,379,000,000 United States dollar | valid 2014-06-30 to 2014-09-30 | conf 0.95 | superseded | superseded_by [clm_D7BAD79013E2](/claim/clm_D7BAD79013E2.md) | [clm_F524606EDD03](/claim/clm_F524606EDD03.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 33,424,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_95358B86E7F7](/claim/clm_95358B86E7F7.md) | [clm_165903BD583C](/claim/clm_165903BD583C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 5,225,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_7ABFC31A8BB3](/claim/clm_7ABFC31A8BB3.md) | [clm_2667BF40F6D4](/claim/clm_2667BF40F6D4.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,531,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_F524606EDD03](/claim/clm_F524606EDD03.md) | [clm_4166B33E0FF5](/claim/clm_4166B33E0FF5.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 937,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_AC6E23B2F9C9](/claim/clm_AC6E23B2F9C9.md) | [clm_C49A2C3D8244](/claim/clm_C49A2C3D8244.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000175/0000014272-14-000175-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 946,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_B68B536C52EB](/claim/clm_B68B536C52EB.md) | [clm_C5B379B462EE](/claim/clm_C5B379B462EE.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000175/0000014272-14-000175-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,657,176,162 shares | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_099A5E3E5A27](/claim/clm_099A5E3E5A27.md) | [clm_DA71505ABBC2](/claim/clm_DA71505ABBC2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000175/0000014272-14-000175-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 3,811,000,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_C0146E275324](/claim/clm_C0146E275324.md) | [clm_FBA07B943AA7](/claim/clm_FBA07B943AA7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000175/0000014272-14-000175-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,650,232,566 shares | valid 2014-01-31 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_DA71505ABBC2](/claim/clm_DA71505ABBC2.md) | [clm_8BCCB5038439](/claim/clm_8BCCB5038439.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 3,731,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_B78350FCAC19](/claim/clm_B78350FCAC19.md) | [clm_7AA4E6476ED6](/claim/clm_7AA4E6476ED6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 3,586,000,000 United States dollar | valid 2013-12-31 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_2667BF40F6D4](/claim/clm_2667BF40F6D4.md) | [clm_9739D1EF5F99](/claim/clm_9739D1EF5F99.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 16,385,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_E35D5B28759F](/claim/clm_E35D5B28759F.md) | [clm_E61BAA33F6AB](/claim/clm_E61BAA33F6AB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 38,592,000,000 United States dollar | valid 2013-12-31 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_165903BD583C](/claim/clm_165903BD583C.md) | [clm_EC7E8D5CA72D](/claim/clm_EC7E8D5CA72D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,154,000,000 United States dollar | valid 2013-12-31 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_4166B33E0FF5](/claim/clm_4166B33E0FF5.md) | [clm_F7A44B0C37D3](/claim/clm_F7A44B0C37D3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 2,563,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_849DE9DA8A78](/claim/clm_849DE9DA8A78.md) | [clm_FED892DDF9CE](/claim/clm_FED892DDF9CE.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 893,000,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_C5B379B462EE](/claim/clm_C5B379B462EE.md) | [clm_27A7E1F022F1](/claim/clm_27A7E1F022F1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427213000029/0000014272-13-000029-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 1,771,000,000 United States dollar | valid 2013-09-30 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_9739D1EF5F99](/claim/clm_9739D1EF5F99.md) | [clm_363905365AEB](/claim/clm_363905365AEB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 692,000,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_C49A2C3D8244](/claim/clm_C49A2C3D8244.md) | [clm_5D173FA6435E](/claim/clm_5D173FA6435E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427213000029/0000014272-13-000029-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,714,000,000 United States dollar | valid 2013-09-30 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_F7A44B0C37D3](/claim/clm_F7A44B0C37D3.md) | [clm_B1D91187EE1D](/claim/clm_B1D91187EE1D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,065,000,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_FBA07B943AA7](/claim/clm_FBA07B943AA7.md) | [clm_B320413C225B](/claim/clm_B320413C225B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427213000029/0000014272-13-000029-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 36,804,000,000 United States dollar | valid 2013-09-30 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_EC7E8D5CA72D](/claim/clm_EC7E8D5CA72D.md) | [clm_C99CF666DA8F](/claim/clm_C99CF666DA8F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,646,542,902 shares | valid 2013-09-30 to 2014-01-31 | conf 0.95 | superseded | superseded_by [clm_8BCCB5038439](/claim/clm_8BCCB5038439.md) | [clm_D362098E13A0](/claim/clm_D362098E13A0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427213000029/0000014272-13-000029-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 536,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_5D173FA6435E](/claim/clm_5D173FA6435E.md) | [clm_0CBE35C30190](/claim/clm_0CBE35C30190.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427213000005/0000014272-13-000005-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 1,821,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_363905365AEB](/claim/clm_363905365AEB.md) | [clm_3B17D68F5937](/claim/clm_3B17D68F5937.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,373,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_B1D91187EE1D](/claim/clm_B1D91187EE1D.md) | [clm_4AC64166F770](/claim/clm_4AC64166F770.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,048,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_B320413C225B](/claim/clm_B320413C225B.md) | [clm_5071BA073AB1](/claim/clm_5071BA073AB1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427213000005/0000014272-13-000005-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 951,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_27A7E1F022F1](/claim/clm_27A7E1F022F1.md) | [clm_8A08DB5FE15E](/claim/clm_8A08DB5FE15E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427213000005/0000014272-13-000005-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 36,252,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_C99CF666DA8F](/claim/clm_C99CF666DA8F.md) | [clm_8A51A9748631](/claim/clm_8A51A9748631.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,646,323,647 shares | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_D362098E13A0](/claim/clm_D362098E13A0.md) | [clm_F86E304869FA](/claim/clm_F86E304869FA.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427213000005/0000014272-13-000005-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,642,551,939 shares | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_F86E304869FA](/claim/clm_F86E304869FA.md) | [clm_1D91FA8CD9C4](/claim/clm_1D91FA8CD9C4.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513172698/0001193125-13-172698-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 1,355,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_3B17D68F5937](/claim/clm_3B17D68F5937.md) | [clm_22BCB38F2FC7](/claim/clm_22BCB38F2FC7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 13,699,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_4AC64166F770](/claim/clm_4AC64166F770.md) | [clm_3CD12612970A](/claim/clm_3CD12612970A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 609,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_0CBE35C30190](/claim/clm_0CBE35C30190.md) | [clm_5A43CA71F161](/claim/clm_5A43CA71F161.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513172698/0001193125-13-172698-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 3,831,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_5071BA073AB1](/claim/clm_5071BA073AB1.md) | [clm_7AD34DF2085B](/claim/clm_7AD34DF2085B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513172698/0001193125-13-172698-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 930,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_8A08DB5FE15E](/claim/clm_8A08DB5FE15E.md) | [clm_87AEB86D7C6E](/claim/clm_87AEB86D7C6E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513172698/0001193125-13-172698-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 35,958,000,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_8A51A9748631](/claim/clm_8A51A9748631.md) | [clm_F99C1BE84142](/claim/clm_F99C1BE84142.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 1,960,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_FED892DDF9CE](/claim/clm_FED892DDF9CE.md) | [clm_13B8A096CB86](/claim/clm_13B8A096CB86.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 17,621,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_E61BAA33F6AB](/claim/clm_E61BAA33F6AB.md) | [clm_184933260070](/claim/clm_184933260070.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 1,656,000,000 United States dollar | valid 2012-12-31 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_22BCB38F2FC7](/claim/clm_22BCB38F2FC7.md) | [clm_2673EE4231F4](/claim/clm_2673EE4231F4.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 3,904,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_7AA4E6476ED6](/claim/clm_7AA4E6476ED6.md) | [clm_28B48A890504](/claim/clm_28B48A890504.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 35,897,000,000 United States dollar | valid 2012-12-31 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_F99C1BE84142](/claim/clm_F99C1BE84142.md) | [clm_8335B31C7803](/claim/clm_8335B31C7803.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 13,623,000,000 United States dollar | valid 2012-12-31 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_3CD12612970A](/claim/clm_3CD12612970A.md) | [clm_B2D5089F7D8F](/claim/clm_B2D5089F7D8F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 1,503,000,000 United States dollar | valid 2012-09-30 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_2673EE4231F4](/claim/clm_2673EE4231F4.md) | [clm_0A3FD4469F2B](/claim/clm_0A3FD4469F2B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 13,900,000,000 United States dollar | valid 2012-09-30 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_B2D5089F7D8F](/claim/clm_B2D5089F7D8F.md) | [clm_30E51F0761D7](/claim/clm_30E51F0761D7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 951,000,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_87AEB86D7C6E](/claim/clm_87AEB86D7C6E.md) | [clm_3A1E9B6A06D0](/claim/clm_3A1E9B6A06D0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512432664/0001193125-12-432664-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 3,736,000,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_7AD34DF2085B](/claim/clm_7AD34DF2085B.md) | [clm_5F4D49DAD603](/claim/clm_5F4D49DAD603.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512432664/0001193125-12-432664-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 36,044,000,000 United States dollar | valid 2012-09-30 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_8335B31C7803](/claim/clm_8335B31C7803.md) | [clm_85051BD0A395](/claim/clm_85051BD0A395.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | -711,000,000 United States dollar | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_5A43CA71F161](/claim/clm_5A43CA71F161.md) | [clm_D544780A3D80](/claim/clm_D544780A3D80.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512432664/0001193125-12-432664-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,650,688,859 shares | valid 2012-09-30 to 2013-03-31 | conf 0.95 | superseded | superseded_by [clm_1D91FA8CD9C4](/claim/clm_1D91FA8CD9C4.md) | [clm_E7B997AAC550](/claim/clm_E7B997AAC550.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512432664/0001193125-12-432664-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 2,801,000,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_0A3FD4469F2B](/claim/clm_0A3FD4469F2B.md) | [clm_32ACB5993B93](/claim/clm_32ACB5993B93.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 645,000,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_D544780A3D80](/claim/clm_D544780A3D80.md) | [clm_400E6A76F107](/claim/clm_400E6A76F107.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512313811/0001193125-12-313811-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 31,667,000,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_85051BD0A395](/claim/clm_85051BD0A395.md) | [clm_4EE281D526FD](/claim/clm_4EE281D526FD.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,443,000,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_5F4D49DAD603](/claim/clm_5F4D49DAD603.md) | [clm_962B22363E26](/claim/clm_962B22363E26.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512313811/0001193125-12-313811-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 962,000,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_3A1E9B6A06D0](/claim/clm_3A1E9B6A06D0.md) | [clm_CB25B0A2ED5C](/claim/clm_CB25B0A2ED5C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512313811/0001193125-12-313811-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,812,000,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_30E51F0761D7](/claim/clm_30E51F0761D7.md) | [clm_D90C800D5F23](/claim/clm_D90C800D5F23.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,679,022,076 shares | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_E7B997AAC550](/claim/clm_E7B997AAC550.md) | [clm_E4AD7E9FAFC7](/claim/clm_E4AD7E9FAFC7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512313811/0001193125-12-313811-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 909,000,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_CB25B0A2ED5C](/claim/clm_CB25B0A2ED5C.md) | [clm_654F010BC1A6](/claim/clm_654F010BC1A6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 2,307,000,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_32ACB5993B93](/claim/clm_32ACB5993B93.md) | [clm_69D36896A414](/claim/clm_69D36896A414.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 32,408,000,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_4EE281D526FD](/claim/clm_4EE281D526FD.md) | [clm_A3954CF64C23](/claim/clm_A3954CF64C23.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_operating_income | 1,402,000,000 United States dollar | valid 2012-03-31 to present | conf 0.95 | valid | [clm_B92B3F0BD51E](/claim/clm_B92B3F0BD51E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 1,101,000,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_400E6A76F107](/claim/clm_400E6A76F107.md) | [clm_BCEA508603AD](/claim/clm_BCEA508603AD.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,689,084,439 shares | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_E4AD7E9FAFC7](/claim/clm_E4AD7E9FAFC7.md) | [clm_C6683CEE0217](/claim/clm_C6683CEE0217.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,251,000,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_962B22363E26](/claim/clm_962B22363E26.md) | [clm_D79B75C428AC](/claim/clm_D79B75C428AC.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 16,246,000,000 United States dollar | valid 2012-03-31 to 2012-06-30 | conf 0.95 | superseded | superseded_by [clm_D90C800D5F23](/claim/clm_D90C800D5F23.md) | [clm_E1F91BE97869](/claim/clm_E1F91BE97869.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,688,107,071 shares | valid 2012-02-01 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_C6683CEE0217](/claim/clm_C6683CEE0217.md) | [clm_82A20B1B8801](/claim/clm_82A20B1B8801.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 32,970,000,000 United States dollar | valid 2011-12-31 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_A3954CF64C23](/claim/clm_A3954CF64C23.md) | [clm_13C65F81B665](/claim/clm_13C65F81B665.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 3,709,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_13B8A096CB86](/claim/clm_13B8A096CB86.md) | [clm_18995E577EB1](/claim/clm_18995E577EB1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 21,244,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_184933260070](/claim/clm_184933260070.md) | [clm_63A21B1FADCA](/claim/clm_63A21B1FADCA.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 5,776,000,000 United States dollar | valid 2011-12-31 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_69D36896A414](/claim/clm_69D36896A414.md) | [clm_724CC60F8B98](/claim/clm_724CC60F8B98.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,956,000,000 United States dollar | valid 2011-12-31 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_E1F91BE97869](/claim/clm_E1F91BE97869.md) | [clm_936DFDC00DD3](/claim/clm_936DFDC00DD3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 3,839,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_28B48A890504](/claim/clm_28B48A890504.md) | [clm_E409DEC1EB09](/claim/clm_E409DEC1EB09.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 32,014,000,000 United States dollar | valid 2011-09-30 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_13C65F81B665](/claim/clm_13C65F81B665.md) | [clm_2694BD596845](/claim/clm_2694BD596845.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 969,000,000 United States dollar | valid 2011-09-30 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_BCEA508603AD](/claim/clm_BCEA508603AD.md) | [clm_47B6838E35BE](/claim/clm_47B6838E35BE.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511283608/0001193125-11-283608-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 973,000,000 United States dollar | valid 2011-09-30 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_654F010BC1A6](/claim/clm_654F010BC1A6.md) | [clm_52390711AFA3](/claim/clm_52390711AFA3.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511283608/0001193125-11-283608-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,345,000,000 United States dollar | valid 2011-09-30 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_D79B75C428AC](/claim/clm_D79B75C428AC.md) | [clm_814D2D7EDE03](/claim/clm_814D2D7EDE03.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511283608/0001193125-11-283608-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 16,436,000,000 United States dollar | valid 2011-09-30 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_936DFDC00DD3](/claim/clm_936DFDC00DD3.md) | [clm_AE4D8667202B](/claim/clm_AE4D8667202B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,694,531,520 shares | valid 2011-09-30 to 2012-02-01 | conf 0.95 | superseded | superseded_by [clm_82A20B1B8801](/claim/clm_82A20B1B8801.md) | [clm_D5297B7922AC](/claim/clm_D5297B7922AC.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511283608/0001193125-11-283608-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 4,471,000,000 United States dollar | valid 2011-09-30 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_724CC60F8B98](/claim/clm_724CC60F8B98.md) | [clm_FA3C67F400B6](/claim/clm_FA3C67F400B6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 16,145,000,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_AE4D8667202B](/claim/clm_AE4D8667202B.md) | [clm_2E2E0A543705](/claim/clm_2E2E0A543705.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 902,000,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_47B6838E35BE](/claim/clm_47B6838E35BE.md) | [clm_39908922AB57](/claim/clm_39908922AB57.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511200164/0001193125-11-200164-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 923,000,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_52390711AFA3](/claim/clm_52390711AFA3.md) | [clm_57CE22C1D3E7](/claim/clm_57CE22C1D3E7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511200164/0001193125-11-200164-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 31,833,000,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_2694BD596845](/claim/clm_2694BD596845.md) | [clm_99C2CB91CAD8](/claim/clm_99C2CB91CAD8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 3,665,000,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_FA3C67F400B6](/claim/clm_FA3C67F400B6.md) | [clm_A562DF98ED52](/claim/clm_A562DF98ED52.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,434,000,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_814D2D7EDE03](/claim/clm_814D2D7EDE03.md) | [clm_E02B6AA5ECE7](/claim/clm_E02B6AA5ECE7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511200164/0001193125-11-200164-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,705,666,684 shares | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_D5297B7922AC](/claim/clm_D5297B7922AC.md) | [clm_EA443BD9D9F9](/claim/clm_EA443BD9D9F9.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511200164/0001193125-11-200164-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 986,000,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_39908922AB57](/claim/clm_39908922AB57.md) | [clm_1923C9EC0F5F](/claim/clm_1923C9EC0F5F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511113907/0001193125-11-113907-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 30,851,000,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_99C2CB91CAD8](/claim/clm_99C2CB91CAD8.md) | [clm_1D31481A724A](/claim/clm_1D31481A724A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 3,405,000,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_A562DF98ED52](/claim/clm_A562DF98ED52.md) | [clm_53D8339DBD3E](/claim/clm_53D8339DBD3E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,011,000,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_E02B6AA5ECE7](/claim/clm_E02B6AA5ECE7.md) | [clm_73076406AD2F](/claim/clm_73076406AD2F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511113907/0001193125-11-113907-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_operating_income | 1,288,000,000 United States dollar | valid 2011-03-31 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_B92B3F0BD51E](/claim/clm_B92B3F0BD51E.md) | [clm_81753CE151BB](/claim/clm_81753CE151BB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,705,988,458 shares | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_EA443BD9D9F9](/claim/clm_EA443BD9D9F9.md) | [clm_93DA371874DF](/claim/clm_93DA371874DF.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511113907/0001193125-11-113907-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 935,000,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_57CE22C1D3E7](/claim/clm_57CE22C1D3E7.md) | [clm_A119CE234655](/claim/clm_A119CE234655.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511113907/0001193125-11-113907-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,901,000,000 United States dollar | valid 2011-03-31 to 2011-06-30 | conf 0.95 | superseded | superseded_by [clm_2E2E0A543705](/claim/clm_2E2E0A543705.md) | [clm_DED765641022](/claim/clm_DED765641022.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,702,427,438 shares | valid 2011-02-01 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_93DA371874DF](/claim/clm_93DA371874DF.md) | [clm_9FDA4D1635BA](/claim/clm_9FDA4D1635BA.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 19,484,000,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_63A21B1FADCA](/claim/clm_63A21B1FADCA.md) | [clm_09D474D26D0F](/claim/clm_09D474D26D0F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 5,033,000,000 United States dollar | valid 2010-12-31 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_53D8339DBD3E](/claim/clm_53D8339DBD3E.md) | [clm_2B15511DC840](/claim/clm_2B15511DC840.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 31,076,000,000 United States dollar | valid 2010-12-31 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_1D31481A724A](/claim/clm_1D31481A724A.md) | [clm_2B3414D511E2](/claim/clm_2B3414D511E2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,713,000,000 United States dollar | valid 2010-12-31 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_DED765641022](/claim/clm_DED765641022.md) | [clm_65A0EE5A7F89](/claim/clm_65A0EE5A7F89.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 3,566,000,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_E409DEC1EB09](/claim/clm_E409DEC1EB09.md) | [clm_6B24FDF6B4D7](/claim/clm_6B24FDF6B4D7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 3,102,000,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_18995E577EB1](/claim/clm_18995E577EB1.md) | [clm_ED3F0DB21357](/claim/clm_ED3F0DB21357.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,970,000,000 United States dollar | valid 2010-09-30 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_65A0EE5A7F89](/claim/clm_65A0EE5A7F89.md) | [clm_5333ECE10209](/claim/clm_5333ECE10209.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 824,000,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_A119CE234655](/claim/clm_A119CE234655.md) | [clm_695BB0FA11F0](/claim/clm_695BB0FA11F0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 31,885,000,000 United States dollar | valid 2010-09-30 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_2B3414D511E2](/claim/clm_2B3414D511E2.md) | [clm_6F0AA4DE7420](/claim/clm_6F0AA4DE7420.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 949,000,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_1923C9EC0F5F](/claim/clm_1923C9EC0F5F.md) | [clm_951D8222BE42](/claim/clm_951D8222BE42.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,798,000,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_73076406AD2F](/claim/clm_73076406AD2F.md) | [clm_953918B58D21](/claim/clm_953918B58D21.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 7,581,000,000 United States dollar | valid 2010-09-30 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_2B15511DC840](/claim/clm_2B15511DC840.md) | [clm_A2A893CB84D0](/claim/clm_A2A893CB84D0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,711,685,361 shares | valid 2010-09-30 to 2011-02-01 | conf 0.95 | superseded | superseded_by [clm_9FDA4D1635BA](/claim/clm_9FDA4D1635BA.md) | [clm_E792F08DCA9E](/claim/clm_E792F08DCA9E.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 822,000,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_695BB0FA11F0](/claim/clm_695BB0FA11F0.md) | [clm_23291C065B20](/claim/clm_23291C065B20.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,714,842,193 shares | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_E792F08DCA9E](/claim/clm_E792F08DCA9E.md) | [clm_26DAB597B294](/claim/clm_26DAB597B294.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 31,051,000,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_6F0AA4DE7420](/claim/clm_6F0AA4DE7420.md) | [clm_590012138198](/claim/clm_590012138198.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,768,000,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_953918B58D21](/claim/clm_953918B58D21.md) | [clm_7E9207656793](/claim/clm_7E9207656793.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 927,000,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_951D8222BE42](/claim/clm_951D8222BE42.md) | [clm_83C2F51E059C](/claim/clm_83C2F51E059C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,668,000,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_5333ECE10209](/claim/clm_5333ECE10209.md) | [clm_9A6F8C68D6D2](/claim/clm_9A6F8C68D6D2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 5,918,000,000 United States dollar | valid 2010-06-30 to 2010-09-30 | conf 0.95 | superseded | superseded_by [clm_A2A893CB84D0](/claim/clm_A2A893CB84D0.md) | [clm_D13C1060B3B6](/claim/clm_D13C1060B3B6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 743,000,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_83C2F51E059C](/claim/clm_83C2F51E059C.md) | [clm_1106AB9EACF1](/claim/clm_1106AB9EACF1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 30,753,000,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_590012138198](/claim/clm_590012138198.md) | [clm_19E988AD4CF7](/claim/clm_19E988AD4CF7.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,719,674,383 shares | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_26DAB597B294](/claim/clm_26DAB597B294.md) | [clm_A2051A49A962](/claim/clm_A2051A49A962.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 5,135,000,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_D13C1060B3B6](/claim/clm_D13C1060B3B6.md) | [clm_AE4EED1D907A](/claim/clm_AE4EED1D907A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 910,000,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_23291C065B20](/claim/clm_23291C065B20.md) | [clm_BF436A5728D0](/claim/clm_BF436A5728D0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 15,249,000,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_9A6F8C68D6D2](/claim/clm_9A6F8C68D6D2.md) | [clm_F593E486E4B0](/claim/clm_F593E486E4B0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,807,000,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_7E9207656793](/claim/clm_7E9207656793.md) | [clm_F86EF4975AB0](/claim/clm_F86EF4975AB0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,714,140,539 shares | valid 2010-02-01 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_A2051A49A962](/claim/clm_A2051A49A962.md) | [clm_7BE350E8CA7A](/claim/clm_7BE350E8CA7A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 31,008,000,000 United States dollar | valid 2009-12-31 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_19E988AD4CF7](/claim/clm_19E988AD4CF7.md) | [clm_1A542B42096D](/claim/clm_1A542B42096D.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 7,683,000,000 United States dollar | valid 2009-12-31 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_AE4EED1D907A](/claim/clm_AE4EED1D907A.md) | [clm_4EFB031CC777](/claim/clm_4EFB031CC777.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 18,808,000,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_09D474D26D0F](/claim/clm_09D474D26D0F.md) | [clm_5E03D7303B2C](/claim/clm_5E03D7303B2C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,843,000,000 United States dollar | valid 2009-12-31 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_F593E486E4B0](/claim/clm_F593E486E4B0.md) | [clm_B283AB8C502B](/claim/clm_B283AB8C502B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 10,612,000,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_ED3F0DB21357](/claim/clm_ED3F0DB21357.md) | [clm_BA69B9ABC777](/claim/clm_BA69B9ABC777.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 3,647,000,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_6B24FDF6B4D7](/claim/clm_6B24FDF6B4D7.md) | [clm_DAABE58B1D2F](/claim/clm_DAABE58B1D2F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 966,000,000 United States dollar | valid 2009-09-30 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_1106AB9EACF1](/claim/clm_1106AB9EACF1.md) | [clm_19F93EC97E86](/claim/clm_19F93EC97E86.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,487,000,000 United States dollar | valid 2009-09-30 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_F86EF4975AB0](/claim/clm_F86EF4975AB0.md) | [clm_80EE21A24A79](/claim/clm_80EE21A24A79.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 838,000,000 United States dollar | valid 2009-09-30 to 2010-03-31 | conf 0.95 | superseded | superseded_by [clm_BF436A5728D0](/claim/clm_BF436A5728D0.md) | [clm_9539553B388C](/claim/clm_9539553B388C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 30,951,000,000 United States dollar | valid 2009-09-30 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_1A542B42096D](/claim/clm_1A542B42096D.md) | [clm_9F6D3418BE8B](/claim/clm_9F6D3418BE8B.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,980,980,141 shares | valid 2009-09-30 to 2010-02-01 | conf 0.95 | superseded | superseded_by [clm_7BE350E8CA7A](/claim/clm_7BE350E8CA7A.md) | [clm_A22CE6E75963](/claim/clm_A22CE6E75963.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 6,367,000,000 United States dollar | valid 2009-09-30 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_4EFB031CC777](/claim/clm_4EFB031CC777.md) | [clm_CEBD9898E6DD](/claim/clm_CEBD9898E6DD.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,518,000,000 United States dollar | valid 2009-09-30 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_B283AB8C502B](/claim/clm_B283AB8C502B.md) | [clm_F1E095F901DB](/claim/clm_F1E095F901DB.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 14,096,000,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_F1E095F901DB](/claim/clm_F1E095F901DB.md) | [clm_19E3172F2603](/claim/clm_19E3172F2603.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,384,000,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_80EE21A24A79](/claim/clm_80EE21A24A79.md) | [clm_23AB41FFB556](/claim/clm_23AB41FFB556.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 7,507,000,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_CEBD9898E6DD](/claim/clm_CEBD9898E6DD.md) | [clm_4924AC9C6DD6](/claim/clm_4924AC9C6DD6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 983,000,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_19F93EC97E86](/claim/clm_19F93EC97E86.md) | [clm_519A562D2C58](/claim/clm_519A562D2C58.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 829,000,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_9539553B388C](/claim/clm_9539553B388C.md) | [clm_7C98CAE61978](/claim/clm_7C98CAE61978.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 29,809,000,000 United States dollar | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_9F6D3418BE8B](/claim/clm_9F6D3418BE8B.md) | [clm_8D8A51B2F4B9](/claim/clm_8D8A51B2F4B9.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | shares_outstanding | 1,980,924,717 shares | valid 2009-06-30 to 2009-09-30 | conf 0.95 | superseded | superseded_by [clm_A22CE6E75963](/claim/clm_A22CE6E75963.md) | [clm_EB69B4618AB6](/claim/clm_EB69B4618AB6.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | x_username | bmsnews | valid 2009-04-21 to present | conf 0.60 | unverified | [clm_7954DAE3098C](/claim/clm_7954DAE3098C.md)
  sources: https://www.wikidata.org/wiki/Q266423
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 7,832,000,000 United States dollar | valid 2009-03-31 to 2009-06-30 | conf 0.95 | superseded | superseded_by [clm_4924AC9C6DD6](/claim/clm_4924AC9C6DD6.md) | [clm_49121E860939](/claim/clm_49121E860939.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 4,322,000,000 United States dollar | valid 2009-03-31 to 2009-06-30 | conf 0.95 | superseded | superseded_by [clm_23AB41FFB556](/claim/clm_23AB41FFB556.md) | [clm_C2AB7EFEF874](/claim/clm_C2AB7EFEF874.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 638,000,000 United States dollar | valid 2009-03-31 to 2009-06-30 | conf 0.95 | superseded | superseded_by [clm_519A562D2C58](/claim/clm_519A562D2C58.md) | [clm_C4DE364B4900](/claim/clm_C4DE364B4900.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 908,000,000 United States dollar | valid 2009-03-31 to 2009-06-30 | conf 0.95 | superseded | superseded_by [clm_7C98CAE61978](/claim/clm_7C98CAE61978.md) | [clm_E1D89EF594F5](/claim/clm_E1D89EF594F5.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 7,976,000,000 United States dollar | valid 2008-12-31 to 2009-03-31 | conf 0.95 | superseded | superseded_by [clm_49121E860939](/claim/clm_49121E860939.md) | [clm_3190F41977D5](/claim/clm_3190F41977D5.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_equity | 12,241,000,000 United States dollar | valid 2008-12-31 to 2009-06-30 | conf 0.95 | superseded | superseded_by [clm_19E3172F2603](/claim/clm_19E3172F2603.md) | [clm_375333654B18](/claim/clm_375333654B18.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 5,247,000,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_BA69B9ABC777](/claim/clm_BA69B9ABC777.md) | [clm_7A0B346282B2](/claim/clm_7A0B346282B2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 3,512,000,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_DAABE58B1D2F](/claim/clm_DAABE58B1D2F.md) | [clm_9CF416D4E085](/claim/clm_9CF416D4E085.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 17,715,000,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_5E03D7303B2C](/claim/clm_5E03D7303B2C.md) | [clm_A34D5877A520](/claim/clm_A34D5877A520.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | total_assets | 29,486,000,000 United States dollar | valid 2008-12-31 to 2009-06-30 | conf 0.95 | superseded | superseded_by [clm_8D8A51B2F4B9](/claim/clm_8D8A51B2F4B9.md) | [clm_D3A5975B919A](/claim/clm_D3A5975B919A.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 7,173,000,000 United States dollar | valid 2008-09-30 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_3190F41977D5](/claim/clm_3190F41977D5.md) | [clm_130C987CF3F0](/claim/clm_130C987CF3F0.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 834,000,000 United States dollar | valid 2008-09-30 to 2009-03-31 | conf 0.95 | superseded | superseded_by [clm_E1D89EF594F5](/claim/clm_E1D89EF594F5.md) | [clm_474970165AA1](/claim/clm_474970165AA1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 2,578,000,000 United States dollar | valid 2008-09-30 to 2009-03-31 | conf 0.95 | superseded | superseded_by [clm_C4DE364B4900](/claim/clm_C4DE364B4900.md) | [clm_F064DBE19873](/claim/clm_F064DBE19873.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,254,000,000 United States dollar | valid 2008-09-30 to 2009-03-31 | conf 0.95 | superseded | superseded_by [clm_C2AB7EFEF874](/claim/clm_C2AB7EFEF874.md) | [clm_F7EF5D23F54F](/claim/clm_F7EF5D23F54F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_revenue | 5,203,000,000 United States dollar | valid 2008-06-30 to 2008-09-30 | conf 0.95 | superseded | superseded_by [clm_F7EF5D23F54F](/claim/clm_F7EF5D23F54F.md) | [clm_BF6999DA6A38](/claim/clm_BF6999DA6A38.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 826,000,000 United States dollar | valid 2008-06-30 to 2008-09-30 | conf 0.95 | superseded | superseded_by [clm_474970165AA1](/claim/clm_474970165AA1.md) | [clm_D4A1B1B0AE97](/claim/clm_D4A1B1B0AE97.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 4,047,000,000 United States dollar | valid 2008-06-30 to 2008-09-30 | conf 0.95 | superseded | superseded_by [clm_130C987CF3F0](/claim/clm_130C987CF3F0.md) | [clm_E1F5893FE2CE](/claim/clm_E1F5893FE2CE.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_net_income | 764,000,000 United States dollar | valid 2008-06-30 to 2008-09-30 | conf 0.95 | superseded | superseded_by [clm_F064DBE19873](/claim/clm_F064DBE19873.md) | [clm_E71C501C8306](/claim/clm_E71C501C8306.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 1,801,000,000 United States dollar | valid 2007-12-31 to 2008-06-30 | conf 0.95 | superseded | superseded_by [clm_E1F5893FE2CE](/claim/clm_E1F5893FE2CE.md) | [clm_0494564B2DA8](/claim/clm_0494564B2DA8.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | research_and_development | 3,160,000,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_9CF416D4E085](/claim/clm_9CF416D4E085.md) | [clm_3176728251F2](/claim/clm_3176728251F2.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | net_income | 2,165,000,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_7A0B346282B2](/claim/clm_7A0B346282B2.md) | [clm_A576452DB99C](/claim/clm_A576452DB99C.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | revenue | 15,617,000,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_A34D5877A520](/claim/clm_A34D5877A520.md) | [clm_C385A7558EA1](/claim/clm_C385A7558EA1.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cash_and_equivalents | 2,018,000,000 United States dollar | valid 2006-12-31 to 2007-12-31 | conf 0.95 | superseded | superseded_by [clm_0494564B2DA8](/claim/clm_0494564B2DA8.md) | [clm_140302496E1F](/claim/clm_140302496E1F.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | website | https://www.bms.com/ | valid undated to present | conf 0.45 | unverified | [clm_6C58446D45ED](/claim/clm_6C58446D45ED.md)
  sources: https://www.wikidata.org/wiki/Q266423
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | ticker | CELG-RI | valid undated to present | conf 0.95 | valid | [clm_1EFB3D1960DA](/claim/clm_1EFB3D1960DA.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | state_of_incorporation | DE | valid undated to present | conf 0.95 | valid | [clm_48211D1EBA75](/claim/clm_48211D1EBA75.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cik | 0000014272 | valid undated to present | conf 0.95 | valid | [clm_772C4FAC73F0](/claim/clm_772C4FAC73F0.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | cfo | David V. Elkins | valid undated to present | conf 0.95 | valid | [clm_7B0B3B31B401](/claim/clm_7B0B3B31B401.md)
  sources: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | listed_on | NYSE | valid undated to present | conf 0.95 | valid | [clm_7C0328B0E90C](/claim/clm_7C0328B0E90C.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | registrant_name | BRISTOL MYERS SQUIBB CO | valid undated to present | conf 0.95 | valid | [clm_B021E66EA136](/claim/clm_B021E66EA136.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | fiscal_year_end | 12-31 | valid undated to present | conf 0.95 | valid | [clm_B055BC429569](/claim/clm_B055BC429569.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | headquarters | Princeton | valid undated to present | conf 0.95 | valid | [clm_C642296F0710](/claim/clm_C642296F0710.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | sic_industry | Pharmaceutical Preparations (2834) | valid undated to present | conf 0.95 | valid | [clm_DF7B0F2F37F6](/claim/clm_DF7B0F2F37F6.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272
- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | ticker | BMY | valid undated to present | conf 0.95 | valid | [clm_ED7EF0279BF9](/claim/clm_ED7EF0279BF9.md)
  sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
